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Zusammenfassung 
 
Hämatopoetische Stammzellen haben die Fähigkeit zur Selbsterneuerung und  
können zu den unterschiedlichen adulten Blutzellentypen differenzieren. Unter 
Erythropoese versteht man den Prozess, in dem myeolide Vorläuferstammzellen 
zu kernlosen hämoglobinisiereten Erythrocyten differenzieren. Hematopoese und 
Erythropoese sind komplexe Abläufe, welche einer strengen Kontrolle unterliegen 
müssen, da eine Störung des Gleichgewichts zwischen Selbsterneuerung, 
Differenzierung und Zellteilung zu ernsten Krankheitsbildern führen kann.  
Steroidhormone, wie z.B. Glukokortikoide, spielen in der Kontrolle über die 
Entscheidung der Selbsterneuerung und Differenzierung zu erythroiden 
Vorläuferzellen eine essentielle Rolle. Glukokortikoide sind außerdem noch in 
verschiedensten Abläufen im Körper involviert, so regulieren sie z.B. den Fett- und 
Eiweißmetabolismus, und sind beteiligt in der Kontrolle bestimmter Funktionen des 
zentralen Nervensystems, sowie des Immunsystems. Glukokortikoide entfalten 
ihre Wirkung durch Bindung an den nukleären Glukokortikoid-Rezeptor (GR). 
Dieser agiert nach erfolgter Aktivierung als Transkriptionsfaktor und moduliert auf 
diese Weise direkt oder indirekt die Gentranskription verschiedenster Zielgene. 
In meiner Diplomarbeit hab ich die Funktion folgender drei GR-Zielgene analysiert: 
Raf-1, Tis11d, FKBP51. Alle Experimente wurden in einem primären erythroiden 
Zellkultur-System durchgeführt, wobei die erythroiden Vorläuferzellen aus 
humanem Nabelschurblut isoliert wurden. Ziel meiner Diplomarbeit war es eine 
verlässliche und reproduzierbare Transfektions-Methode zu etablieren, mit deren 
Hilfe ich die Expression aller drei GR-Zielgene durch Elektroporation mit siRNAs 
erfolgreich vermindern konnte. Ziel der Runterregulierung war es, dadurch die 
Funktion derselben Gene herauszufinden. Dafür wurden morphologische 
Veränderungen in den Zellen, Effekte auf deren Viabilität und auf andere 
Signalwege analysiert. Im Laufe meiner Arbeit konnte ich zeigen, dass eine 
verminderete Expression von Tis11d und FKBP51 eine erhöhte Apoptose zur 
Folge hatte. Daraus konnte geschlossen werden, dass Tis11d und FKBP51 
womöglich in anti-apoptotischen Mechanismen in erythroiden Vorläuferzellen 
involviert sind. Doch die genauen molekularbiologischen Hintergründe, sowie die 
möglich involvierten Signalwege müssen noch ausführlicher untersucht werden. 
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 Abstract 
 
Hematopoietic stem cells (HSCs) are able to self-renew and to differentiate into all 
mature blood cell types, during erythropoiesis early erythroid progenitor cells 
differentiate into enucleated red blood cells (RBC). Hematopoiesis and 
erythropoiesis are complex processes, which have to be under strict control, 
disturbance of the balance between self-renewal, proliferation and differentiation 
results in severe diseases.  
Steroid hormones, such as glucocorticoids, have been shown to be one of the key 
regulators of the decision between self-renewal and differentiation into erythroid 
progenitor cells. Glucocorticoids have been demonstrated to be involved in the 
regulation of numerous other physiological and developmental processes 
throughout the body, such as regulation of lipid and protein metabolism, regulation 
of central nervous system functions and modulation of the immune system. 
Glucocortiocids bind to their nuclear receptor (GR), which then functions as a 
transcription factor and induces expression or inhibition of various target genes. 
Glucocorticoid Receptor functions are essential for survival, since mice lacking the 
GR die at birth and show defects on several organs (Cole et al., 1995). 
In my diploma thesis I studied the function of the three different glucocorticoid 
target genes: Raf-1, Tis11d and FKBP51. All of the experiments were performed in 
a primary erythroid cell culture system, derived from umbilical cord blood.  
During my diploma thesis I established a reliable and reproducible method for 
transfection of human EPCs by electroporation. With this method I could 
successfully knock down all three target genes by electroporation with 
complementary siRNAs. Downregulation of Raf-1, Tis11d and FKBP51 gave us 
insights into their function and the mechanisms in which they are involved during 
erythroid cell proliferation and spontaneous differentiation. Morphological changes, 
effects on the cell viability and changes in downstream signaling after the knock-
down were analysed. While there were no remarkable effects after the Raf-1 
knock-down, we could show that downregulation of Tis11d and FKBP51 led to an 
increase of apoptosis. This indicates that both GR-target genes are involved in 
anti-apoptotic mechanisms within erythroid progenitor cells. The exact regulation 
of the survival pathway needs further investigation. 
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1. Introduction 
 
1.1 Human Hematopoiesis  
 
Hematopoiesis is the process where all types of blood cells of the hematopoietic 
system, the white leuko- and lymphocytes and the red blood cells, are formed from 
hematopoietic stem cells (HSCs) (see figure 1 and 2) (Tsiftsoglou et al., 2009). 
The red colour of the blood is the result of the accumulated hemoglobin in the 
erythrocytes. Erythrocytes are responsible for the oxygen transport through the 
body. As oxygen transport is a stressful process and is causing damage to the 
erythrocytes, the lifespan of erythrocytes is limited to approximately 90 to 120 days. 
Therefore it is essential for the organism to produce new red blood cells 
throughout the whole life of an individual. This is achieved by differentiation of 
hematopoietic stem cells into progenitor cells and finally into mature enucleated 
erythrocytes (Orkin and Zon, 2008). 
 
HSCs are able to perform self-renewal, which means that a cell can divide into 
two daughter cells, where one cell is able to differente and the other cell is 
maintained in the undifferentiated stem cell-like state. Due to its ability of self-
renew, one single hematopoietic stem cell could generate an entire hematopoietic 
system and thereby maintain hematopoiesis for the lifetime of one individual (Orkin 
and Zon, 2008; Renstrom et al., 2009).  
The processes of self renewal and differentiation have to be strictly and tightly 
controlled, and a failure in the regulation of HSCs can lead to a variety of diseases, 
such as leukaemia or anaemia (Carlesso and Cardoso, 2010). (Carlesso and 
Cardoso) 
 
Primitive and definitive haematopoiesis 
 
Human hematopoiesis can be divided into primitive and definitive hematopoiesis. 
From week 3-6 of gestation, hematopoiesis takes place in the yolk sac (primitive 
erythropoiesis), wheareas from week 6-22 the fetal liver functions as the primary 
site of hematopoiesis; after this period the bone marrow becomes the predominant 
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and lifelong site of blood-cell- production (definitive haematopoiesis, see figure 1) 
(Bonifer et al., 1998; Palis and Yoder, 2001). 
 
 
 
Figure 1: Human hematopoiesis 
Hematopoiesis begins in the bone marrow, where a pluripotent long-term HSC 
gives rise to a short-term HSC, which turns into a multipotent hematopoietic 
progenitor cell. Such multipotent hematopoietic progenitor cells then undergo 
several steps of differentiaton and generate the common myeloid progenitor 
(CMP) and the common lymphoid progenitor (CLP), which can differentiate into 
T- and B- lymphocytes, natural killer cells and dendritic cells.  
The common myeloid progenitor cells turn into granulocyte-myeloid progenitors 
(GMP) and into megakaryocytic/erythroid progenitors (MEP), which can 
differentiate into erythroid burst forming unit-erythroid (BFU-E) and colony 
forming unit-erythroid (CFU-E). The CFU-Es then mature into enucleated 
erythrocytes (red blood cells, RBCs); (picture taken from Tsiftsoglou et al., 2009).  
Introduction 
11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Maturation and differentiation in human hematopoiesis 
Hematopoietic stem cells (HSC) give rise to all types of blood cells of the hematopoietic system. 
Blood cells can be classified into two main groups: lymphoid cells (T, B, and natural killer cells) 
and myeloid cells (granulocytes, monocytes, erythrocytes and megakaryocytes). 
(picture taken from: Alexander Fleming, Biomedical Sciences Research Center: 
www.fleming.gr/en/investigators/Strouboulis/index.htm) 
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1.1.2 Hematopoietic stem cells and their niches  
 
HSCs are able to self-renew and to differentiate into blood cells of multiple 
lineages (see figure 1 and figure 2). The fate of stem cells is controlled by a 
specific microenvironment, the stem cell niche (Renstrom et al., 2009). In adults 
the niche of HSC is the bone marrow microenvironment, which provides intrinsic 
and extrinsic factors crucial for the maintainance the stem cell properties of HSCs.  
The stem cell niche is a highly organized three-dimensional microenvironment, 
which consists of different cell types (the HSCs and other niche cells), soluble 
factors derived from the niche cells (Lin, 2002) and the extracellular matrix, formed 
mainly by fibronectin and collagen (Arai et al., 2005). 
Within the stem cell niche cell-cell-interactions and interactions between the 
HSCs and the extracellular matrix take place. Such interactions are essential for 
the balance between self-renewal, differentiation and cell-cycle quiescence (see 
figure 4) (Wilson and Trumpp, 2006). 
 
The HSC niche consists of two parts: the vascular niche and the osteoblastic 
niche (Yin and Li, 2006). The vascular niche supports the differentiation into 
hematopoietic progenitor cells, whereas the osteoblastic niche maintains HSC in a 
quiescent state with slow cycling or in G0-state. By keeping HSC in a quiescent 
state it is ensured that their potential for long-term hematopoiesis is maintained 
and premature exhaustion of HSCs is prevented (Shiozawa et al., 2008). In the 
osteoblastic and vascular niche cytokine signaling pathways such as Ang-1/Tie2, 
THPO/Mpl (see figure 3) and SCF/cKIT play an important role in the regulation 
and maintainance of HSCs (Arai et al., 2009). 
 
Angiopoietin-1 (Ang-1) is a ligand for the Tie2 receptor on the surface of HSCs. 
By binding to its receptor, Angiopoetin-1 activates Tie2 and thereby promotes the 
interaction of HSCs with the extracellular matrix of the niche. Thereby it induces 
adhesion of HSCs to fibronectin and collagen, which keeps the HSCs within the 
niche. The Tie2/Ang-1 signaling promotes quiescence, apoptosis protection as 
well as tight adhesion. By preventing cell division of HSCs, Ang-1 maintains the 
long-term blood-repopulating activity (Arai et al., 2005). 
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Thrombopoetin (THPO) is produced in the osteoblastic island, THPO and its 
receptor Mpl maintain HSCs quiescence. It has been demonstrated that inhibiton 
of the Trombopoetin/Mpl signaling-pathway reduces the interactions of HSCs to 
the niche and this susequentely results in reduction of the quiescent HSC 
population (Arai et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stem cell factor (SCF) is one of the most important hematopoietic growth factors. 
It is produced by fibroblasts and endothelial cells within the niche and it stimulates 
the proliferation of primitive hematopoietic cells. SCF binds to its receptor c-kit, 
which is expressed on the surface of HSCs. The SCF/c-kit signaling plays an 
important role in migration, survival, proliferation and differentiation of HSC in the 
bone marrow niche (Nakamura et al., 2004). It has been reported that loss of SCF 
leads to hematopoietic failure (Bernstein et al., 1991) and  that SCF might 
therefore have an essential role in the control of HSC activation and the 
mobilization of HSCs from the niche into the blood stream (Heissig et al., 2002; 
Yin and Li, 2006). 
Under stress and injury, the c-kit ligand is converted into soluble Kit ligand (s-kit), 
it can bind to SCF with the same affinity as c-kit. Thereby s-kit inhibits the ability of 
SCF to bind to the HSC. This inhibition stimulates the entry of HSCs into the cell 
Figure 3: The HSC niche 
 
Cytokine signaling pathways 
such as THPO/Mpl and Ang-
1/Tie2 between HSCs and 
osteblastic niche cells promote 
cell adhesion, which contributes 
to HSC quiescence. 
 
(taken from: Arai et al., 2009) 
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cycle, the mobilization to the vascular niche and the differentiation. The 
Mechanisms that regulate the HSCs mobilization are not fully understood up to 
now (Nakamura et al., 2004). 
 
 
 
 
 
Figure 4: Niches for HSCs in adult bone marrow  
 
The niche in the bone marrow (a,b) can be divided into two parts: the osteoblastic niche 
and the vascular niche (c). While the vascular niche supports the differentiation into 
hematopoietic progenitor cells and the mobilization into the blood stream (d), the 
osteoblastic niche keeps the balance between self-renewal and cell-cycle quiescence. (e) 
In the osteoblatic niche the HSCs adhere to the niche cells through the adhesion 
molecules and through factors produced by osteoblasts so that the HSCs are kept in a 
quiescence state. Picture taken from: (Shiozawa et al., 2008) 
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1.2 Human erythropoiesis 
 
During erythropoesis, early erythroid progenitor cells differentiate into enucleated 
red blood cells (RBC) (Palis, 2008). Eryhtropoiesis is a process of multiple stages 
and depends on the correct balance between cell proliferation, differentiation and 
apoptosis (Orkin and Zon, 2008; Weissman, 2000). The disruption of this 
equilibrium/balance leads to haematological diseases like aplastic anaemia and 
thalassemia (Testa, 2004).  
Figure 5 a):  
 
 
 
Erythropoiesis is a process of multiple differentiation 
steps , see figure 5 a) and figure 5 b):  
The myeolid stem cell gives rise to the pronormoblast. 
When the cytoplasm becomes more basophilic due to 
the presence of ribosomes, the pronormoblast has 
turned into a basophilic normoblast. 
During the ongoing development the nucleus shrinks, 
the cell becomes smaller and begins to produce 
hemoglobin. At this stage the cell is called 
polychromatophilic normoblast.  
When the nucleus moves to the periphery of the cell and 
the cytoplasm becomes more eosinophilic, the cell 
converts into an orthochromatic normoblast.  
When the orthochromatic normoblast extrudes its 
nucleus, it enters the blood circulation as a 
reticulocyte. Reticulocytes were named after the 
characteristic reticular networks of polyribosomes which 
they contain. After 1-2 days reticulocytes loose their 
polyribosomes and become mature red blood cells 
(erythrocytes). 
Mature erytrhocytes are biconcave disks without 
nucleus, mitochondria and other organelles and their 
main function is to bind oxygen through the 
accumulated hemoglobin (Tsiftsoglou et al., 2009). 
 
Picture taken and modified from: 
http://sakurako.iza.ne.jp/blog/entry/1362003/ 
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Figure 5 b): The differentiation steps in erythropoiesis     
Hematopoietic stem cell becomes commited (pronormoblat) and differentiates into early 
basophilic normoblast, which contains ribosomes (phase 1), then the the basophilic 
normoblast (or early erythroblast) accumulates iron and hemoglobin (phase 2) and finally 
ejects organelles and the nucleus (phase 3) and is released into blood stream as a 
reticulocyte, where it differentiates into a mature erythrocyte. Picture from taken from:  
http://legacy.owensboro.kctcs.edu/gcaplan/anat2/notes/Notes6%20Blood%20Cells.htm 
 
 
When erythrocytes differentiate starting from HSC, the cells undergo characteristic 
changes: The nucleus of hematopoietic stem cells is big and contains open 
chromatin. When HSC mature into red blood cells, the chromatin of the nucleus 
condenses and the cytoplasmic matrix increases in amount, the cytoplasm turns 
from basophilic to acidophilic due to the decrease in the amount of RNA and DNA, 
the nucleus decreases in size and is finally extruded. In the process of maturation 
a basophilic pronormoblast is converted from a cell with a large nucleus and a 
volume of 900 fL to an enucleated disc with a volume of 95 fL (Testa, 2004). 
 
 
1.2.1 Erythropoiesis takes place in erythroblastic islands 
 
Erythropoiesis takes place in the bone marrow in the so called erythroblastic 
islands (Allen and Dexter, 1982). Erythroblastic islands are microenvironmental 
compartments, where erythroblasts proliferate and differentiate into mature 
reticulocytes (Bessis, 1958). Those islands consist of a central macrophage 
surrounded by developing erythroblasts of various differentiation stages (see 
figure 6) (Bessis, 1958; Tsiftsoglou et al., 2009).  
The number of erythroblasts surrounding the macrophages can vary from 5 to 30 
erythroblasts per island. Erythroblastic islands are distributed over the entire bone 
marrow and are not localized to specific regions (Chasis, 2006). 
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The central macrophage has been shown to function as a “nurse” cell, as it is 
providing the iron for the hemoglobin synthesis and other nutrients needed for 
erythropoiesis (Bessis and Breton-Gorius, 1962). It gives proliferative and survival 
signals to the erythroblasts and takes up the nuclei from the enucleated 
orthochromatic normoblasts by phagocytosis (Chasis, 2006; Skutelsky and Danon, 
1972). There is also evidence that macrophages are promoting the enucleation 
itself. The cultivation of erythroblasts in the absence of macrophages leads to 
decreased erythroid cell proliferation, maturation and enucleation as well as 
increased apoptosis (Chasis and Mohandas, 2008).   
 
Macrophages secrete several cytokines, which stimulate the differentiation and 
proliferation, like for example insulinlike growth factor-1 (IGF-1), that has been 
shown to stimulate growth of erythroblasts (Kurtz et al., 1982).  
In macrophages also the mRNA of erythropoetin (EPO) has been detected (Rich 
et al., 1988), which suggests that they could provide EPO to the surrounding 
erythroblasts and thereby stimulate differentiation and inhibit apoptosis.  
 
Within the erythroblastic islands erythropoesis is regulated by positive and 
negative feedback loops, which occur by soluble factors. Such soluble factors are 
for example SCF, EPO and VEGF, which activate erythropoiesis via positive 
feedback mechanisms, whereas IL-6, TGF-ß, TNF-α and IFN- are inhibiting 
erythropoiesis and promoting cell death of erythroblasts. IL-6, for example, is 
inhibiting the iron release from the central macrophage in the erythroblastic island 
(Tsiftsoglou et al., 2009).  
 
Also the cell-cell interactions between the erythroblasts and the central 
macrophages trigger intracellular signaling pathways, which then lead to changes 
in differentiation-, proliferation- and apoptosis- related processes (Chasis and 
Mohandas, 2008). And components of the extracellular matrix, like fibronectin 
and laminin influence terminal differentiation and migration of erythroid cells by 
interacting with fibronectin receptors on the surface of erythroblasts (Chasis and 
Mohandas, 2008). 
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Erythroblastic islands 
 
a)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b)
Figure 6:  
Erythropoiesis occures in 
erythroblastic islands 
 
 
a) Developing erythro-
blasts of different stages of 
maturation surround a 
central macrophage, which 
is providing iron for the 
hemoglobin synthesis, 
takes up extruded nuclei 
from differentiating normo-
blasts and thereby stimu-
lates the differentiation into 
reticulocytes.  
(Chasis and Mohandas, 
2008) 
 
 
 
 
 
 
 
b) Scanning electron 
micrograph of an isolated 
erythroblastic islands. 
Arrow shows enucleating 
erythroblast.  
(Chasis and Mohandas, 
2008) 
 
Introduction 
19 
 
1.3 Clinical use of HSCs 
 
During postnatal life HSCs populate a very small compartment, less than 0,05% 
up to 0,5% of the cells in the bone marrow consist of HSCs (Gunsilius et al., 
2001), it is estimated that 1 in 10,000 bone marrow cells and 1 in every 100.000 
blood cells are hematopoietic stem cells. HSCs can be used to treat bone marrow 
failure and aplastic anaemia by transplantation of HLA-identical allogeneic 
hematopoietic progenitors (Congdon, 1957; Kondo et al., 2003). The source of 
HSCs for transplantation can be the bone marrow, but also autologous HSCs 
isolated from peripheral blood can be used for restoration of hematopoiesis in 
patients with malignant diseases after chemotherapy (Gunsilius et al., 2001). 
Another clinical use in the future could be the use of genetically modified HSC to 
cure metabolic defects even at embryonal stage, but this method is still under 
investigation and is still far away from clinical use. After transplantation of 
allogeneic or autologous HSCs, hematopoiesis can be restored and maintained by 
a small number of clones. Besides bone marrow and mobilised peripheral blood, in 
the last years umbilical cord blood was found to be a good source of 
hematopoietic stem cells.  
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 7: Clinical use of HSCs isolated from umbilical cord blood  
(picture taken from: www.vivocell.org) 
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Compared to the bone marrow, the use of mobilized blood stem cells from the 
peripheral blood or the cord blood has the advantage of a more rapid 
hematopoietic recovery, therefore they are slowly replacing the bone marrow as 
alternative source of stem cells. The umbilical cord blood is richer in stem cells 
with a higher proliferative potential than bone marrow or peripheral blood 
(Gunsilius et al. 2001). But the drawback is that just a limited number of HSCs can 
be isolated from a single umbilical cord blood sample. The required amount of 
HSC for transplantation is 2x106 CD34+ cells/kg body weight. In umbilical cord 
blood, the percentage of CD34 + stem cells is about 1% of the mononucleated 
cells. Therefore, the minimum cell dose required for restoration of haematopoiesis 
in adult patients can usually not be reached using HSCs from a single umbilical 
cord blood sample. One solution for the problem of too low HSC numbers isolated 
from one cord blood could be the in vitro expansion of HSCs leading to cell 
numbers that are high enough for the transplantation in adults. Therefore CD34+ 
cells could be cultivated for seven to 14 days in a liquid culture system with a 
combination of various cytokines (e.g. SCF, IL-3, IL-6, EPO) and then re-infused to 
the patients. But it has been reported that expansion of HSC in vitro led also to 
differentiation of the cells, whereby the stem cell potential and the life-long self-
renewal capacity of the expanded cells got lost (Gunsilius et al., 2001). 
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1.4 Erythroid cells in culture 
 
Although up to know the expansion of HSCs is not optimised yet, the cultivation of 
primary erythroid progenitor cells isolated from human cord blood is a valuable 
model system for the study of hematopoiesis in vitro or ex vivo. Mononuclear cells 
can be isolated from human cord blood samples, expanded in serum free medium 
to human erythroid progenitor cells (hEPCs) and subsequentlty induced for 
terminal erythroid differentiation (Dolznig et al., 2005; Leberbauer et al., 2005). 
 
The so expanded EPCs show renewal and differentiation characteristics, which 
are similar to the in vivo situation. In comparison to other primary model systems, 
which often suffer from insufficient cell numbers or from heterogeneity of cell 
populations, the EPCs can be expanded to high numbers keeping a homogeneous 
cell population.  
 
Steady state erythropoiesis involves just a limitied number of differentiation 
divisions and is controlled mainly by Erythropoietin (EPO). Stress erythropoiesis 
in vivo is induced by hypoxia or anaemia and is co-regulated by erythropoietin, 
stem cell factor and glucocorticoids. Ex vivo expanded erythroid progenitor cells 
mimic the process of stress erythropoiesis, as they are cultivated in serum free 
medium, which is supplementd with those factors, which are active in stress 
erythropoiesis: low EPO, SCF and DEX (Dolznig et al., 2005; Kolbus et al., 2003). 
In this model system, cells retain the proerythroblast phenotype, but can also be 
induced to terminally differentiate, if the renewal factors are replaced by 
differentiation factors: high EPO, Insulin (Dolznig et al., 2005). 
 
This in vitro expansion system can be used as a model to study molecular and 
cellular events of hematopoiesis and additionally used to find the best conditions 
to enable an in vitro expansion of hematopoietic stem cells to high numbers of 
progenitor cells, which then could be used for transfusion in patients suffering from 
hematological disorders.  
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1.4.1 Growth factors for in vitro proliferation   
 
For in vitro expansion of human erythroid progenitor cells, the mononuclear cells 
isolated from cord blood samples can be cultivated in serum free medium, 
supplemented with a factor mix of EPO, SCF, DEX, IGF-1 and Lipids.  
 
EPO- Erythropoietin 
Epo is one of the most important factors in the regulation of erythropoiesis, it is 
produced mainly in the fetal liver and the adult kidney. EPO binds to its receptor 
(EpoR), which is a member of the hematopoietic cytokine receptor superfamily, 
whereby the receptor undergoes a conformational change and activates several 
pathways. Signal transduction by EPO is mediated through the EpoR/Jak2/Stat 
signalling cascade (Miura et al., 1994; Witthuhn et al., 1993). It has been reported 
that EPO protects erythroid progenitor cells from apoptosis by activating 
antiapoptotic proteins like Bcl-X(L) (Dolznig et al., 2002) and that it is essential for 
terminal differentiation by stimulating hemoglobin synthesis (Dorn et al., 2008). 
EPO-deficient mice or mice lacking the EpoR die at the embryonic stage of 
abscence of definitive erythrocytes (Lin et al., 1996). 
 
SCF- stem cell factor 
SCF is an important proliferation factor that plays an essential role in 
hematopoiesis: it promotes proliferation of erythroid progenitor cells by stimulating 
DNA synthesis (Dorn et al., 2008).  SCF is a member of the type III superfamily of 
receptor tyrosine kinases. It is expressed mainly in hematopoietic progenitor cells, 
B- and T- cell progenitors, mast cells and germ cells (Tsiftsoglou et al., 2009). 
In mice deficient for the receptor of SCF, c-Kit, erythrocytes are generated, but 
these KO-mice die at birth because of severe anaemia and their bone marrow 
contains a reduced number of erythroid progenitors (Broxmeyer et al., 1991; 
Nocka et al., 1990).  
 
SCF and EPO are both required for the proliferation and survival of erythroid 
progenitor cells in vitro. During terminal erythroid differentiation, the stem cell 
receptor c-kit is downregulated, whereas EPO becomes the essential survival 
factor. If EPO and SCF were added simultaneously to an in vitro culture of hEPCs, 
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it has been shown that the proliferative effects were additive, which suggests that 
SCF and EPO might cooperate with each other. Importantly, when EPO was 
added alone and in higher concentrations, differentiation was induced (Muta et al., 
1995; Muta et al., 1994). 
 
DEX- Dexamethasone 
Addition of glucocorticoids, like Dexamethasone (DEX), is required to ensure 
optimal proliferation rates of in vitro cultures with low spontaneous differentiation. 
Dexamethasone regulates a variety of developmental processes by binding to the 
glucocorticoid receptor (GR) and thereby activating the glucocorticoid receptor 
pathway. Leberbauer et al. could demonstrate that dexamethasone stimulates 
proliferation and blocks spontaneous differentiation of erythroid progenitors 
(Leberbauer et al., 2005). In vivo the GR is required for stress erythropoiesis. It 
has been reported that GR-deficient- mice are viable, show normal erythropoiesis, 
but show no stress-induced erythrpoiesis in spleen, which means they could not 
respond to hypoxia or blood loss with increased erythroblast renewal (Bauer et al., 
1999). In chicken and mouse erythroblasts, the activated GR cooperates with the 
activated EpoR and c-kit (SCF receptor). This cooperation keeps erythroid 
progenitor cells in an immature state and induces long-term proliferation (Wessely 
et al., 1997). A similar effect of glucocorticoids has been described in human 
erythroblasts (von Lindern et al., 1999). 
 
IGF-1- Interleukin-growth factor-1 
Panzenböck et al. demonstrated that addition of Interleukin-growth-factor-1 
(IGF-1) to the serum-free cultures also stimulates proliferation and inhibits 
differentiation of hEPCs. IGF-1 appears not to be a crucial growth factor, but it 
does further improve the proliferation conditions (Panzenbock et al., 1998).  
 
Lipids 
In addition, cholesterol-rich Lipids were found to be essential for the extended 
proliferation of human EPCs. Addition of Lipids extended the proliferation periode 
from 30 to 45 days (Leberbauer et al., 2005).   
Introduction 
 
24 
 
Addition of fetal bovine serum (FBS) was shown to limit the expansion of 
erythroid progenitor cells compared to serum-free medium, even when the crucial 
factors like EPO, SCF and DEX were provided (Leberbauer et al., 2005).  
In summary, a combination of EPO, SCF, IGF-1, DEX and Lipids in serum free 
media are the best culture conditions to reach optimal proliferation rates of human 
erythroid progenitor cells.  
 
 
1.5 Glucocorticoid Receptor (GR) 
 
Glucocorticoids have an important function in multiple physiological and 
developmental processes. By binding to its receptor (GR), glucocorticoids 
modulate the activity of various target genes, which then influence the 
differentiation and proliferation of e. g. hematopoietic stem cells.  
The GR cooperates with the activated EpoR (EPO Receptor), and c-Kit (SCF 
Receptor) to maintain erythroid cells in an immature state, inhibit terminal 
differentiation and to maintain the long-term proliferation potential of these cells 
(Dolznig et al., 2006; Srivastava et al., 2006). 
 
The Glucocorticoid Receptor is a steroid hormone receptor that belongs to the 
nuclear receptor superfamily of transcription factors (Revollo and Cidlowski, 2009). 
Glucocorticoids are the most widely prescribed pharmaceuticals worldwide and 
key drugs for treating disesases like hematological cancers (leukemia, 
inflammatory states). The GR has a DNA binding domain (DBD) with which it can 
interact directly with target genes that contain a glucocorticoid response element 
(GREs) or a negative glucocorticoid response element (nGREs) in their promotor 
region, see figure 8 (Wessely et al., 1997).  
 
The Glucocorticoid Receptor is a ligand-regulated transcription factor, which in 
abscence of glucocorticoids is situated in the cytoplasm in an inactive form, where 
it is associated with the heat shock protein 90 chaperone complex, that keeps the 
receptor inactive (Paakinaho et al.). 
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Figure 8: The Glucocorticoid Signaling 
Glucocorticoid signaling induces changes in gene expression. When Glucocorticoids bind 
to the GR, the ligand-bound-GR-complex dissociates and translocates into the nucleus, 
where it can activate or inhibit gene expression by protein-protein interaction with 
Transcription factors, like STAT5 or NFkB or by directly binding to DNA with their DNA 
binding domain via GRE or nGREs (GRE=Glucocorticoid Response Elements) 
(nGREs=negative Glucocorticoid Response Elements); (picture taken from: (Revollo and 
Cidlowski, 2009). 
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1.5.1 Glucocorticoid signaling 
 
When the ligand (different glucocorticoids) binds to its receptor (GR), the receptor 
is activated, and dissociation of the Ligand-bound-GR-complex is induced (Amaral 
et al., 2009; Stellacci et al., 2009). The activated receptor then translocates to the 
nucleus, where it acts as a transcription factor and influences gene expression in 
two ways:  
 
It can either activate or inactivate gene expression: 
→ by protein-protein interaction: it associates directly with transcription factors, 
like STAT5 or NF-kB, and thereby activates or inhibits the transcription of specific 
target genes.  
→ by direct DNA binding: it can directly bind to target genes on DNA level by 
associating with high affinity to short DNA sequences (DNA binding sites: via 
GREs and nGREs) (Revollo and Cidlowski, 2009). 
 
 
1.5.2 Glucocorticoid Receptor and erythropoiesis 
 
The Glucocorticoid Receptor is a key regulator of the decision between self 
renewal and differentiation of erythroid progenitors.  
Dexamethasone in combination with SCF and EPO, has been shown to down-
regulate GATA-3 expression and to up-regulate the expression of GATA-1 
(Srivastava et al., 2006).  
GATA-1 and GATA-3 are members of the GATA gene family. Members of this 
family are expressed at very early stages of hematopoiesis and are key regulators 
of proliferation and survival of early hematopoietic cells under the influence of 
factors such as glucocorticoids, SCF and EPO (Srivastava et al., 2006). In media 
lacking a GR ligand or containing a GR antagonist, erythroid progenitors faile to 
self-renew (Wessely et al., 1997). In avians glucocorticoids were shown to 
stimulate the formation of erythroid colonies in vitro. In the presence of 
glucocorticoids lower concentrations of erythropoietin are required to induce 
maximal erythroid cell proliferation (Udupa et al., 1986). 
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1.5.3 Glucocorticoid Receptor target genes 
 
In a microarray screen performed with RNA from EPCs stimulated with 
Dexamethasone (alone or in combination with different factors), several target 
genes of the GR have been identified, as they were either upregulated or 
downregulated in the prescence of DEX (Kolbus et al., 2003; Rubiolo et al., 2006) 
and data not shown). The most prominent upregulated GR-targets genes were: 
Raf-1, Tis11d and FKBP51. 
 
 Raf-1 
Raf-1 is a 74 kDa serine/threonine kinase that is located in the cell cytoplasm 
and is activated by phosphorylation (Muszynski et al., 1997). The Raf kinases are 
key signal transducers that are activated by mitogens or oncogenes.  
During differentiation of primary mouse erythroblasts Raf-1 has been 
demonstrated to be downregulated (Kolbus et al., 2002). 
Raf-1 deficient mouse embryos are anaemic, and die at midgestation with 
anomalies in the placenta and fetal liver, which contained lower numbers of 
erythroid progenitors than the wild type livers (Mikula et al., 2001). The in vivo and 
in vitro studies with genetically modified fibroblasts and hematopoietic cells 
(Kolbus et al., 2002; Mikula et al., 2001), revealed that in summary in the mouse 
system the main functions of Raf-1 are: 
 
→ the inhibition of apoptosis 
→ the stimulation of proliferation and 
→ the regulation of erythroid maturation by delaying erythroid differentiation     
     through inhibition of caspase activation. 
 
 
 Tis11d 
Also Tis11d, a zinc-finger-like protein and member of the TTP protein family, 
has been shown to be a GR- target gene in erythroid progenitor cells. Members of 
the Tis11-family of proteins contain two tandemly repeated zinc finger motifs, by 
which they can bind to adenine-urididine rich elements in different mRNAs. They 
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have been reported to induce degradation of a variety of different mRNAs, 
containing AU-rich elements in the 3’ untranslated region (Baou et al., 2009). 
Since many mRNA transcripts contain AREs, it is possible that glucocorticoid 
signaling regulates the expression of many genes in this manner (Revollo and 
Cidlowski, 2009). Little is known about the function of Tis11d in humans and 
generally in erythropoiesis. Glucocorticoids have been reported to induce TIS11 
mRNA and protein in lung epithelial cells and this induction may be important for 
the glucocorticoid mediated control of inflammatory gene expression (Smoak and 
Cidlowski, 2006). It has been demonstrated that fetal liver cells isolated from 
Zfp36l2 knock-out mice (Zfp36l2 is the synonym for Tis11d in the mouse system) 
were unable to reconstitute the hematopoietic systems in lethally irradiated WT-
mice, which suggests that Zfp36l2 might be required for self-renewal and 
maintenance of adult HSCs (Stumpo et al., 2009). These studies demonstrate that 
Zfp36l2 plays an important role in definitive hematopoiesis during mouse 
development, but little is known about the specific function of Tis11d in human 
erythropoiesis. 
 
 FKBP51 
FKBP51 (FK506-binding protein 51) is a 51 kDA co-chaperone protein, which 
belongs to the immunophilin protein family and is a component of the heat shock 
protein 90 chaperone complex (HSP90 complex). This immunophilin has 
isomerase activity, which performs important biological functions in the cell. The 
immunophilin family is a highly homologous multigene family, which is containing 
at least 5 other proteins, that can bind to the protein FK506 (Park et al., 2007; 
Romano et al.). In a recent genome-wide profiling of human lung biopsies, 
FKBP51 has been identified as the most highly glucocorticoid-induced gene 
(Woodruff et al., 2007). FKBP51 is expressed in various human cell tissues, 
mainly in brain, muscle, liver and thymus (Vermeer et al., 2003). Overexpression 
of FKBP51 limits the Glucocorticoid Receptor signaling. In human A549 lung 
cancer cells, glucocorticoid (Dex) exposure led to a rapid accumulation of FKBP51 
mRNA (Paakinaho et al.). The specific function of FKBP51 in hematopoietic cells 
is not fully understood up to now, but it is estimated that it may play an important 
role in cell survival, proliferation and differentiation (Giraudier et al., 2002). 
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1.6 Apoptotic pathways  
 
Apoptosis or programmed cell death is a highly regulated process, which allows a 
cell to self-degrade. Cell death is a fundamental cellular response that plays an 
important role in development and homeostasis of multicellular organisms.  
As shown in figure 9 below, apoptosis involves specific morphological and 
biochemical changes within the cell, such as cytoplasm condensation, nucleus 
shrinkage, nuclear chromatin condensation, loss of mitochondral membrane 
potential and DNA fragmentation. These processes are then followed by breakage 
of the cells into membrane-bound apoptotic bodies, that contain a variety of 
cytoplasmic organelles and nuclear fragments, which finally are engulfed by 
surrounding cells (Testa, 2004; Van Herreweghe et al., 2010). The apoptotic 
process can be divided into three phases: initiation, integration/decision and 
degradation. The initiation stage is heterogenous and depends on the type of 
apoptosis-inducing stimulus.  During the integration phase caspases and 
mitochondrial effectors are activated, while in the execution stage the cell is 
broken into cell fragments.  
 
Figure 9: Morphological changes within the cell during the apoptotic process 
(picture taken from: www.scq.ubc.ca/apoptosis) 
 
Introduction 
 
30 
 
The cysteinyl aspartate proteinases, called Caspases play a central role in the 
regulation and control of apoptosis. They are a group of evolutionarily conserved 
proteases, which can be found in nearly all animal cells. In recent years it has 
been shown that Caspases are not only involved in apoptosis, but also in other 
cellular processes. High levels of Caspase activation lead to apoptosis, whereas 
low levels of activated Caspases have been shown to play a role in cell 
proliferation and differentiation of erythroid cells and macrophages (Droin et al., 
2008). Caspases are synthesized within a cell as inactive percursors: the 
Procaspases. The inactive percursors can be activated by cleavage into a big and 
a small subunit. Caspases can be classified into Initiator Caspases (Caspase-2, -
8, -9, -10) and Effector Caspases (Caspase-3, -4, -5, -6, -7, -11, -12, -13). 
Initiator Caspases function as activators of Effector Caspases. Caspase-8 for 
example promotes cleavage and thereby activation of various downstream 
Caspases, such as Caspase-3, -6 and -7. Activated Effector Caspases in turn 
induce degradation of regulatory proteins within the cell (Amaral et al., 2009; Van 
Herreweghe et al., 2010). 
When cells undergo apoptosis several pathways can be involved. In mammalian 
cells the apoptotic response is mediated either by an instrinsic or extrinsic pathway. 
Both pathways are Caspase-dependent, but different Caspases are involved.  
The extrinsic pathway is initiated through the stimulation of transmembrane death 
receptors, such as TNF-Receptor1 (TNF-R1) or Fas, which are located on the 
surface of the cell membrane, wheareas the intrinsic pathway is initiated through 
the release of signalling factors by mitochondria within the cell.  
 
 
1.6.1 The extrinsic pathway  
 
In the extrinsic pathway (see figure 10 and 11), soluble ligands, such as FasL or 
TNF-α, bind to their transmembrane death receptors. For example TNF-α binds 
to the TNF-R1 and FasL binds to the Fas-Receptor. The binding of TNF-α to the 
TNF-R1 induces a conformational change of the receptor. This conformational 
change leads to recruitement of RIP1 (protein serine-threonine kinase 1) and 
binding of the adaptor protein TRADD (TNF-receptor associated via death domain) 
to the death domain (DD) of the receptor on the cytoplasmic side (see figure 10). 
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Subsequently, TRADD recruites FADD (Fas-associated via death domain), 
another adaptor protein, which binds to the TRADD/RIP-complex on the death 
domain of the receptor. FADD then induces recruitement of the Procaspase-8 (an 
Effector Caspase) to form the death-inducing signal complex (DISC).  
At a high concentration, the Procaspase-8 induces its autoproteolytic activation 
and is further activated by dimerisation into the active Caspase-8 form. This 
activation is sufficient to induce apoptosis. In the extrinsic pathway, the activated 
Caspase-8 directly activates the Effector Caspase Caspase-3, which initiates the 
degradation of the cell and thereby induces apoptosis (Amaral et al., 2009; Van 
Herreweghe et al., 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10:  The extrinsic 
and instrinsic pathway 
 If TNF-α binds to its receptor 
TNF-R, a conformational 
change of the receptor is 
induced and the 
RIP1/TRADD/FADD complex 
is build. By binding to this 
complex the Caspase-8 is 
activated and apoptosis is 
induced either through the 
extrinsic or intrinsic pathway. 
In the extrinsic pathway 
Caspase-8 induces direct 
Caspase-3 activation, where-
as in the intrinsic pathway 
Caspase-3 activation is 
induced after activation of 
proteins of the BCL-2-family. 
Picture taken and modified 
from:  
(Rahman and McFadden, 
2006). 
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1.6.2 The intrinsic pathway 
 
The intrinsic pathway (see figure 11) is regulated by proteins of the BCL-2-family, 
such as BAX (Bcl-2-associated X protein) and BAK (Bcl-2- antagonist/killer), 
which are activated by BID (BH3 interacting domain death agonist). These pro-
apoptotic proteins are crucial in regulating a wide range of apoptotic stimuli. The 
antiapoptotic members of the BCL-2-family like Bcl-2, are mainly localized in the 
outer mitochondrial membrane, wheareas proapoptotic members, such as BAX 
and BAK are situated in the cytosol as inactive percursors. After induction of 
apoptosis, BAK and BAX undergo conformational changes, oligomerize and 
translocate from the cytosol to the outer mitochondrial membrane.  
 
The intrinsic pathway is triggered by cellular stress or activated Caspase-8. Active 
Caspase-8 can cleave BID to tBID, which in turn activates BAX and BAK. Active 
BAX binds to its receptors in the outer membrane of the mitochondria. The 
insertion of BAX in the mitochondrial outer membrane is required for the pore 
formation, which results in mitochondrial outer mebrane permeability (MOMP). 
This permeability induces the release of cytochrome c and other mitochondrial 
factors. Cytochrom c then binds to the subunit of APAF-1 (apoptotic peptidase 
activating factor 1), which induces conformational change of APAF-1 and thereby 
its activation through hydrolysis of ATP.  
 
A complex of seven activated APAF-1-molecules is forming the so called 
apoptosome, which binds to the Procaspase-9 (Initiator Caspase) and induces its 
activation. The so activated Caspase-9 is interacting with the apoptosome, and 
thereby inducing the activation of Procaspase-3 or -7 by proteolytic cleavage. 
Activated Caspase-3 and -7 are then inducing cell degradation and apoptosis by 
cleavage of many proteins from different cellular compartments, leading finally to 
the cellular disintegration (Amaral et al., 2009; Van Herreweghe et al., 2010). 
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1.6.3 NF-kB activation inhibits apoptosis 
 
Binding of TNF-α to its receptor, can either induce apoptosis through the extrinsic 
or intrinsic pathway, or activate NF-kB (nuclear factor kappa B) (see figure 11). 
The transcription factor NF-kB plays a critical role in inflammation, control of cell 
death pathways and cell proliferation. There are 5 known members of the NF-kB 
family: NF-kB1 (p50/p105), NF-kB2 (p52/p100), c-Rel, RelB and RelA (p65). All 
different members are distinguished by the Rel homology domain, the part of the 
protein that controles the DNA binding. They form various homodimers and 
heterodimers bound to DNA (Adli et al., ; Bouwmeester et al., 2004).  
 
The transcriptional activity of NF-kB is controlled by its intracellular localization. 
NF-kB is located as an inactive form in the cytoplasm, where it is associated with 
the inhibitor proteins IkBs. In most mammalian cells, IkBα and IkB-β represent 
the two major forms of the IkB family. The phosphorylation of the serine residues 
of the IkB proteins leads to the proteolysis by the 26S proteasome, which results in 
the liberation of NF-kB and its translocation into the nucleus.  
 
It has been demonstrated that the NF-kB pathway can be induced by TNF-α 
(Bouwmeester et al., 2004). Thus, RIP-1, which together with TRADD is bound to 
the death domain of the activated TNF-R1, leads to direct association of TRAF2. 
The binding of TRAF2 to the RIP-1/TRADD/TNF-R1 complex is crucial for the 
activation of the NF-kB pathway. TRAF2 recruits the multicomponent protein 
kinase IKKαβ, which is then activated and phosphorylated by RIP1. IKK can be 
activated by phosphorylation in response to a variety of stimuli not only by the 
TNF-R (see chapter 4.3 of this study). pIKKαβ in turn phosphorylates IkB-α, which 
leads to degradation of IkBα and NF-kB release.  
 
NF-kB translocates to the nucleus and thereby accumulates and mediates the 
transcription of anti-apoptotic factors and of a variety of proteins, which are 
involved in cell survival and proliferation (Komura et al., 2005; Merkhofer et al.). 
Introduction 
 
34 
 
  
 
 
 
Figure 11: TNF-α mediated pathways 
If TNF-α binds to its receptor TNF-R1, either apoptosis can be induced or NF-kB is activated. 
After building of the RIP1/TRADD/FADD complex either Caspase-8 is activated and apoptosis 
is induced through the extrinsic or intrinsic pathway, or NF-kB is activated, through 
phosphorilation of IKK, which in turn phosphorilates IKB and induces release of NF-kB into the 
nucleus, where it can stimulate the expression of different pro-apoptotic genes. (Picture taken 
and modified from: Krakstad and Chekenya, 2010). (Krakstad and Chekenya) 
 
 
 
 
 
 
  
 
Introduction 
35 
 
1.7 Cell-surface markers for human erythroid progenitor cells  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Characterization of hEPCs (d14) regarding their surface markers by 
FACS analysis (picture taken with the consent of Dr. Mario Mairhofer) 
 
 
Erythroid progenitor cells can be distinguished by their surface markers: 
depending on their stage of differentiation they express different types of markers. 
In humans CD34 was described as a marker for hematopoietic stem cells 
(Gangenahalli et al., 2006). CD34 expression has been found in immature stem 
cells and committed progenitors. One to three percent of cells in the bone marrow 
express CD34, whereas in the peripheral blood CD34+ cells are extremely rare 
(less than 0,1%). In umbilical cord blood around 1% of the mononuclear cells 
express CD34. With the increase of differentiation the expression level of CD34 
decreases (Baum, Christopher 2009, Genetic Modification of Hematopoietic Stem 
Cells. Methods in Molecular Biology, volume 506, Springer Protocols, page 13.). 
 
 In the present study, cultures of hEPCs isolated from umbilical coord blood are 
used. These cells are negative for CD34, but express high levels of CD71, CD36, 
CD29, CD44, CD117 and CD235a. 
R1
CD36 CD71 CD117 CD33
CD133
CD44
CD31
CD235a CD29 CD45 CD30 CD14
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 CD71 (the transferrin receptor) is expressed on many proliferating cells, but the 
very strong, homogeneous expression is characteristic for erythroid cells. The 
transferrin receptor CD71 is needed for the iron transport into proliferating cells, 
and it is lost when hEPCs differentiate into mature erythrocytes (Leberbauer et 
al., 2005). 
 
 CD36 is a receptor for thrombospondin and is a very early marker for erythroid 
maturation, it is found on the surface of erythroid progenitors, but also on 
monocytes and platelets, but not on lymphocytes and granulocytes.  
 
 CD29, also known as integrin-ß-1, is a transmembrane glycoprotein, which 
forms heterodimers with integrin alpha subunits. It can mediate a variety of 
cellular responses including adhesion, proliferation and differentiation.  
 
 CD44 is it is a cell adhesion receptor that binds to components of the 
extracellular matrix and is widley expressed on hematopoietic and non-
hematopoietic cells. Bone marrow derived progenitor cells, which are 
expressing CD44, have been shown to be able to repopulate the thymus 
(Rajasagi et al., 2009). 
 
 CD117, the c-KIT receptor, is a tyrosine kinase receptor. High CD117 
expression is typical for erythroid progenitors. As already mentioned SCF and 
its receptor play an essential role in the proliferation and differentiation of HSCs 
and hEPCs. Leberbauer et al. reported that freshly isolated mononuclear cells 
from human cord blood expressed very low CD117 levels, while around d14 of 
the cell culture almost 100% of the cells were CD117 positive (Leberbauer et 
al., 2005). 
 
 CD235a, also known as Glycophorin A, is a transmembrane glycoprotein that 
is expressed on mature erythrocytes and erythroid precursors (Auffray et al., 
2001). It is a marker for erythroid differentiation, the more differentiated the 
cells are, the higher Glycophorin A expression is. 
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1.8 RNA interference (RNAi) pathway 
 
In this study the Glucocorticoid Receptor target genes were downregulated by a 
knock-down approach via electroporation with siRNA- oligonucleotides. Silencing 
of a target mRNA by siRNAs is a powerful tool to study gene function. siRNAs are 
double-stranded RNA (dsRNA) molecules of 21-23 nucleotides with characteristic 
2-nucleotide overhanging 3’ ends (Tulac et al., 2004). Through the electroporation-
method target genes can be silenced post- transcriptionally by sequence-specific 
mRNA degradation. Normally siRNAs act as intermediates in the RNA 
interference pathway (RNAi) (see figure 13), which is active in the cells to protect 
mammalian cells from infection by a variety of viruses (Zamore and Aronin, 2003). 
Therefore the ribonuclease Dicer generates siRNAs by cleaving long dsRNAs. In 
the RNA-interference pathway siRNA strands associate with another set of 
proteins to form a protein-enzyme complex, called RNA-induced silencing 
complex (RISC).  
 
 
 
Figure 13: RNA- interference pathway  
(picture taken from: http://hades1.bioquant.uni-heidelberg.de/rnai.html) 
RISC directs the protein-enzyme 
complex to mRNAs which are 
complementary to the siRNA strand. 
After binding to the mRNA, RISC 
induces mRNA-degradation by 
cutting it once. After cleavage the 
RISC-complex binds to the next 
complementary mRNA and begins 
with a new cycle of mRNA- 
cleavage. With this mechanism 
siRNAs are able to induce 
degradation of complementary 
mRNAs, which has made siRNAs to 
an important tool for knock-down 
induction of various target genes 
(Zamore and Aronin, 2003). 
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1.8.1 The electroporation method 
 
siRNAs can be introduced into cells by electroporation. In the 1970s it has been 
demonstrated for the first time that applying electrical pulses to cells enabeles 
increased uptake of biological materials into cells. Nowadays, electroporation has 
become an important tool for nucleic acid delivery into various cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
By the application of a brief, controlled electrical pulse on the cells, a temporarily 
enhanced permeability of pores in the cell membrane is created (see figure 14). 
During this short periode of time (some milisecoconds), in which these pores exist, 
a significant quantitiy of the biomolecules of the sorrounding medium is taken up 
into the cells. After some miliseconds the pores in the membrane reseal and the 
cell membrane returns to its original state. Introducing siRNAs (small interfering 
RNAs) into cells by electroporation has become an important and powerful tool to 
study gene function.   
 
(For more information about electroporation: 
www.iovio.com/technology/howelectroporationworks.htm) 
 
Figure 14: The phenomenon of electroporation  
By applying an electrical pulse on cells, the cell membrane becomes porouse for a short 
periode of time. Thereby DNA-fragments or siRNAs can be introduced into cells. (picture 
taken from: www.iovio.com/technology/howelectroporationworks.htm) 
 
Cell membrane 
before pulsing 
Cell membrane 
during pulsing 
Cell membrane 
after pulsing 
(cell returns to  
original state) 
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Aim of this work:  
 
Human erythroid progenitor cells (hEPCs) undergo renewal in response to 
erythropoietin (EPO), stem cell factor (SCF) and glucocorticoids.  
Glucocorticoids are a class of steroid hormones that regulate a variety of essential 
biological functions. They have anti-inflammatory and immunosuppressive 
properties and have been shown to mediate apoptosis. Glucocorticoids repress or 
activate gene expression by binding to their nuclear receptor, the Glucocorticoid 
Receptor. Interaction of glucocorticoids with their receptor leads to activation and 
translocation of GR into the nucleus, where it acts as a transcription factor and 
modulates the activity of different target genes by binding to the DNA regulatory 
DNA binding sites. Thereby the GR can influence several developmental and 
biological processes.  
 
Aim of this work is to study the function of different glucocorticoid target genes. In 
previous work with mouse EPCs and in a microarray screen where EPCs were 
stimulated with DEX alone or in combination with EPO, SCF and GR inhibitors, 
Raf-1, Tis11d and FKBP51, among others, have been identified to be 
glucocorticoid target genes (Kolbus et al., 2003; Rubiolo et al., 2006) and data not 
shown.  
We chose to analyse the functions of these three GR-target genes in human 
primary erythroid progenitor cells by a transient, siRNA-mediated knock-down 
approach. During my diploma thesis I established a reliable and reproducible 
method for transfection of human EPCs by electroporation. With this method I 
could successfully downregulate all three target genes by siRNA electroporation. 
Thus I studied the effects of the knock-downs on proliferation, spontaneous 
differentiation and cell viability in primary hEPCs from different cord blood donors. 
The obtained results give us insights into the function of these specific GR-target 
genes and the mechanisms in which they are involved during erythroid cell 
proliferation and differntiation.  
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2. Materials and Methods 
 
 
2.1 Working with human erythroid progenitor cells (hEPCs) 
 
 
2.1.1 Isolation of mononuclear blood cells via a Ficoll-gradient 
 
Mononuclear cells were isolated from human umbilical cord blood by a Ficoll-
gradient. Cord blood was obtained in heparin-vials from General Hospital Vienna, 
Medical University of Vienna, Department of Obstetrics and Gynaecology after 
signing of an informed cosent, that has been approved by the local Ethical 
Comission.  
 
 Approximatley 15mL of human cord blood were transfered into a sterile 
50mL-tube and mixed well with 30mL PBS (blood-PBS-ratio: 1:2).  
 Then 15ml of a Ficoll-paque solution (Biocoll, Biochrom AG) was overlayed 
carefully with 15mL of the diluted blood in a 50mL- tube 
 The step gradient was centrifuged for 20 minutes at 1660rpm (300xg) at 
room temperature (important: without break).  
 Note: Ficoll induces aggregation of erythrocytes by which they completely 
sediment through the Ficoll solution and are therefore located at the bottom 
of the 50mL-tube.  While Granulocytes were situated in the layer 
immediatley above the erythrocytes, the mononuclear white blood cells 
(erythroid progenitors, lymphocytes, platelets and monocytes) were 
localized in the interface between the plasma and the Ficoll due to their 
lower density.  
 This interface was collected in a preferably small volume, mixed with PBS 
(1:2) and centrifuged for 5 minutes with 1200rpm (250xg). (This time with 
break).  
 The pellet was then resuspended in approximatley 2,5mL of PBS, filled up 
with 1x erylysis-Buffer 1/25 (v/v) to 50mL  
 The mixture was incubated for 15-20 minutes at room temperature to 
remove also the rest of the red blood cells by erylysis. (10x Erylysis Buffer: 
89,9g Annoniumchlorid, 10g KHCO3 (Kaliumhydrogencarbonat), 0,37g 
EDTA, add A.d. up to 1000mL (pH 7,3), sterile filtratated) 
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 After incubation, the cell suspension was centrifuged at 1200rpm (250xg) 
for 5minutes and the cell pellet was resuspended in 10mL PBS.  
 After counting the cells by a CASY cell analyzer, the suspesion was 
centrifuged at 1200rpm for 5minutes  
 The cell pellet then was either frozen in 10x106 cell- aliquotes or was 
resuspended in an appropriate amount of 1x proliferation-medium and kept 
in culture (at a cell density of approximatly 8x106 cells/mL up to 1x107 
cells/mL).  
 
 
 
 
2.1.2 Isolation of mononuclear blood cells without a Ficoll-gradient  
 
Mononuclear cells could also be isolated from human cord blood without Ficoll-
gradient:  
 
 Therefore 2,5 to 3mL of cord blood were transferred into a sterile 50mL-
tube and filled up with 1x erylysis-Buffer 1/25 (v/v) to 50mL  
 The tubes were incubated for 15-20 minutes at room temperature. During 
this time lysis of red blood cells takes place and therefore the suspension 
loses its viscosity and its dark red colour turns into light red.  
 Then the cell suspension was centrifuged for 10 minutes at 1200rpm (250xg) 
 The supernatant was removed and the different cell pellets of one cord 
blood were first resuspended in 10mL PBS, transferred into a 50mL-tube 
and filled up with PBS to 50mL.  
 After mixing well, the cell-suspension was washed 2 times with 50mL PBS 
by centrifuging at 1200rpm (250xg) for 5 minutes.  
 Then the cell pellet was resuspended in 10mL PBS and 50µl of the cell 
suspension were taken out for cell counting by the electronic cell counter 
(CASY-1, Schärfe-System).  
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After having established the amount of isolated mononuclear cells, the suspension 
was centrifuged again for 5 minutes at 1200rpm (250xg) and the cell pellet was 
then either frozen in 10x106 cell- aliquotes or resuspended in the appropiate 
amount of 1x proliferation media and kept in culture (at a cell density of 
approximatly 8x106 cells/mL up to 1x107 cells/mL).  
 
 
 
10x Erylysis Buffer:  89,9g Ammoniumchlorid 
10g KHCO3 (Kaliumhydrogencarbonat) 
 0,37g EDTA, add A.d. up to 100mL (pH 7,3) 
      → sterile filtered 
 
 
 
2.1.3 Determination of cell number by CASY 
 
To monitor number and size of cultured cells, they were characterized every day 
with a CASY cell analyzer (Schärfe-System, Reutlingen, Germany).  
 
 Therefore the cell suspension was gently resuspended and 50µl of cell 
suspension were diluted 1:100 with CASYton (Schärfe-System Reutlingen, 
Germany) and an aliquot of 200µl of the mixture was then measured by the 
CASY cell analyzer.  
 The measurement was performed with a 60µm capillary, since the 
evaluated cells had a diameter between 5 and 15µm, depending on their 
differtiation stage.  
 The CASY- counts and -profliles are used as quality control to compare 
different preparations of EPCs.  
 With the obtained data the proliferation rates were calculated, moreover 
also the spontaneous differentiation or apoptosis could be detected and 
overall the outgrowth of hEPCs out of mononuclear cells was monitored. 
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2.1.4 Outgrowth of hEPCs from cord blood mononuclear cells  
 
After isolation from human cord blood samples, mononuclear cells were cultivated 
for ten days at 37°C, 5% CO2 and 100% humidity in serum free StemSpan 
medium (StemCellTechnologies) supplemented with the following factors:  
 
 Epo (Erythropoietin)   2U/mL Jannsen-Cilag 
 DEX (Dexamethasone)   1µM/mL Sigma-Aldrich 
 IGF-1 (Interleukin-growth-factor-1) 40ng/mL Sigma-Aldrich 
 SCF (Stem cell factor)   100ng/mL Peprotech/Sigma 
 Cholesterol-rich lipid mix  20µg/mL Sigma-Aldrich 
 
 
This 1x proliferation-medium was also used for long-term cultivation, after the 
cultures have reached homogeneity (>95% erythroid cells) by day 6-10. Partial 
medium changes were performed every 24h to ensure optimal factor supply. After 
outgrowth of EPCs, the cell counts were adjusted to 1x106 cells/mL daily.  
 
After isolation from human cord blood the cell suspension was heterogenous, as 
besides the rare erythroid and multipotent progenitor cells, it was mainly 
containing other types of mononuclear cells (granulocytes, B- and T-leukocytes, 
monocytes).  
During the first six days in culture those other cell types died off and around day 6 
erythroid progenitor cells began to accumulate.  
 
Cells were counted every day by the CASY-cell-analyzer and as soon as the plate 
contained more than 2x106 cells, the culture was kept at a cell density of 1x106 
cells/mL.  
 
Around d10 cell aliquots of 10x106 hEPCs were frozen in cryotubes and stored in 
liquid nitrogen or cells were kept in culture till around d12 to d14, when they were 
ready for experiments.  
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2.1.5 Freezing erythroid progenitor cells 
 
 The cell-suspension was centrifuged in a sterile plastic centrifuge-tube at 
1200rpm (250g) for 5minutes 
  The cell pellet was then resuspended in freezing medium (either FCS and 
10% of DMSO or FILOCETH medium (Fischer Scientifics). DMSO protects 
the cell membranes during the freezing process.  
 Preferentially aliquots of 10x106cells were frozen in cryotubes in 1mL 
freezing medium.  
 The cells were cooled down slowly to -80°C, either in an isopropanol box 
(Mr. Frosty), which provides a cooling rate of -1°C/ minute to prevent cell 
damage by a too quick freezing process. 
 Cell-aliquots were transfered into a liquid N2 tank on the next day.  
 
 
 
 
2.1.6 Thawing erythroid progenitor cells 
 
 Cell aliquots were thawed quickly in a 37°C wather bath (approximatly 3-
5minutes) 
 Then the cell suspension was transferred into a sterile plastic centrifuge-
tube, where 10ml of pre-warmed StemSpan medium (without proliferation 
factors) were added drop by drop, while gently shaking the tube.  
 The cell suspension was centrifuged for 5minutes at 1200rpm (250g) to 
remove all of the DMSO, which is toxic for the cells at high concentrations.  
 The supernatant was therefore removed and the cell pellet was 
resuspended in pre-warmed serum free StemSpan media supplemented 
with 1x proliferation factors and transfered into a culture-dish at a cell 
density of 1x106 cells/mL.  
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2.1.7 Histological staining of erythroid cells with benzidine 
 
50-100µl of the cell suspension were cyto-centrifuged onto a glass-slide (150xg for 
7minutes) and stained according the following protocol. The glass slides were 
stained as described in the protocol below:  
The methanol is fixing and permeabilizing the cells on the slide, the benzidine is 
reacting with the accumulated haemoglobin in the cytoplasm. H2O2 is then 
interacting with the bound benzidine, which leads to a brown staining of 
haemoglobinized cells. The Diff. Quick RED solution is staining the cytoplasm and 
the Diff. Quick BLUE solution the nuclei.  
 
The H2O2 solution was always prepaired fresh (75mL Ethanol, 75mL H2O, 2,5mL 
hydrogen peroxide. The dried slides were mounted with Entellan (Merck) and a 
cover slip and analysed under the microscope.  
 
 
Working steps Time 
 
Incubation in methanol 
 
4min 
Incubation in 1% benzidine solution 
(2g O-Diamisidine dissolved in 200mL MetOH) 
2min 
Incubation in H2O2 solution (fresh!)  
 
1,5 min 
Washing in milliQ water  
 
0,5 min 
Stain with Diff. Quick RED (I)  
 
4min 
Stain with Diff. Quick BLUE (II)  
 
35 sec 
Washing in milliQ water 
 
40sec 
Dry by air 
 
/ 
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2.2 Flow Cytometry (FACS) 
 
FACS (Fluorescence Activated Cell Sorting) is a powerful method to study and 
purify cells and has wide applications in immunology, cell biology and in other 
branches of biology. Cells can be stained with specific fluorescently labeled 
antibodies or other proteins (Annexin-V). During meassurement the cells pass 
through one or more laser beams and cells, to which specific fluorescently labeled 
antibodies or proteins have bound, are stimulated by the laser light and thereby 
they emit light at various frequencies. Photomultiplier tubes convert this light to 
electrical signals and cell data is collected. Thereby cells can for example be 
sorted and counted according to specific surface markers, or proteins expressed 
on their surface (like Annexin-V). 
 
 
2.2.1 Propidium-Iodide staining 
Propidiumiodide (PI) is a standard flow cytometric viability probe. PI can be used 
to distinguish viable from non viable cells. Viable cells with intact membranes 
exclude PI, whereas the membrane of dead and damaged cells is permeable to PI.   
 
PI-Staining: 
 100.000 cells were transferred into FACS tubes 
 The suspension was washed two times with 1x PBS (250xg, for 5minutes) 
 The cells then were resuspended in 500µl PBS+1%FCS 
 5µl of PI were added immediatly before the meassurment 
 The cells were vortexed and meassured by FACS 
 
 
2.2.2 Propidium-Iodide and Annexin-V staining 
When cells undergo apoptosis they show certain morphological chages, like for 
example loss of plasma membrane asymmetry, condensation of the cytoplasm 
and nucleus. Loss of plasma membrane asymmetry is one of the earliest features. 
In apoptotic cells the phospholipid phosphatidylserine (PS) is translocated from the 
inner to the outer leaflet of the plasma membrane and the cells are therefore 
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exposing PS to the cellular environment. Annexin-V is a 35-36kDa phospholipid-
binding protein and in the analyses, this Annexin-V protein was flourescently 
labelled, can bind to the PS positive cells and can be used for flow cytometric 
analysis. Therefore Annexin-V positive cells can be identified as the cells 
undergoing apoptosis at an early stage.  
 
Annexin-V- Staining: 
 100.000 cells were transfered into FACS-tubes  
 The cell suspenstion was washed twice with 1mL 1xPBS (1250xg, 5minutes) 
 the cells were resuspended in 100µl 1x Annexin-V binding buffer (BD 
Bioscience) 
 Then 5µl of Annexin-V solution were added 
 The mixture was incubated for 15minutes at room temperature (in the dark) 
 Then 400µl of 1x Annexin-V binding buffer were added 
 5µl of Propidiumiodide (PI) were added (directly before the meassurment) 
 vortexed and meassured by FACS 
 
Informations about AnnexinV- and PI- staining: datasheet and homepage of BD 
Bioscience. 
 
 
2.2.3 Fixing cells for FACS-analysis 
 
If meassurement by FACS analysis couldn’t be performed immediately, cells were 
fixed as following: 
 1x105 to 2x106 cells/mL were transferred into FACS tubes 
 centrifuged at 1200 rpm (250xg) for 5 minutes 
 cell pellet was resuspended in 2mL 1x PBS 
 centrifuged at 1200 rpm (250xg) for 5 minutes 
 cell pellet was resuspended in 4% Paraformaldehyd (PFA= 500µl PBS 
mixed with 500µl 8% PFA) 
 cell suspension was incubated for 15minutes at room temperature 
 stored at 4°C (note: fixed cells can be stored at 4°C for approximatley 
2weeks) 
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2.2.4 Surface marker staining 
 
To characterize the hEPCs in culture, the expression of specific surface markers 
was analysed.  The different markers can be stained with specific antibodies and 
subsequentely analyzed by FACS-measurements.  
 
 For each meassurement approximatley 500.000 cells are needed, therefore 
the appropriate amount of the cell suspension is resuspended and 
transferred into a sterile 50mL plastic tube. 
 Mixed with 10mL of 1x PBS and centrifuged for 5minutes at 1200rpm 
(250xg) 
 The cell pellet is resuspended with the appropriate amount of 1x 
PBS+1%FCS (50mL PBS and 500µl FCS). (NOTE: 500.000 cells are 
resususpended in 100µl of PBS+1%FCS, if you had 20 different 
approaches, the pellet was resuspended in 2mL) 
 100µl of the cell suspenstion (approximatley 500.000 cells) was transfered 
into a FACS-tube  
 10µl of the specific antibody was added to each tube (2µl of the antibody to 
100.000 cells as recommended by the manufacturer) 
 after short vortexing the mixture was incubated for 30 minutes at 4°C 
 then it was centrifuged for 5 minutes at 1200rpm (250xg) and the cell pellet 
was resuspended in 500µl of PBS+1%FCS 
 the samples were ready to be measured by FACS 
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2.3 Electroporation 
 
 
The electroporation was performed as mentioned below:  
 
After thawing, the cells were first kept in culture for 2-3days to enable the cells to 
recover from the stressful freezing- and thawing-process. We mainly performed 
the electroporation with hEPCs cultured for 12-14 days. 
Per approach, always 2x106 cells were electroporated in a volume of 200µl of        
Opti-MEM(R) medium with the optimized settings 300V and 150µF. (Note: Opti-
MEM(R) is a low-salt medium Transfection Reagent from Invitrogen). The cells first 
had to be washed and prepared for the electroporation. 
 
 The cell suspension was resuspended and counted with the CASY cell 
analyzer  
 Per approach always 2x106 cells were needed, depending on the cell-
concentration the amount of the cell suspension needed for one experiment 
was calculated (for example: For 6 approaches 12x106 cells  (2x106cells x 6) 
were needed, if cell density was 1x106 cells/ml, 12mL of cell suspension 
was used) 
 The appropriate amount of the suspension was transferred into a sterile 
50mL tube. (Note: As through the washing steps some cells will get lost, 
instead of 12mL→ 13 to 13,5mL were taken). 
 The cell suspension was filled up to 50mL with ice cooled Opti-MEM(R)  
 Centrifuged at 1200rpm (250xg) for 5minutes 
 The cell pellet was resuspended in 50mL of ice cooled Opti-MEM(R) and 
centrifuged again for 5minutes at 1200rpm (250xg). 
 In the meanwhile 1x proliferation media was prepared and prewarmed at 
37°C in the waterbath 
 The sterile electroporation cuvettes were labeled and placed on ice (the 
temperature of the cuvettes influences the time-constant) 
 Then the cell pellet was resuspended in the appropriate amount of Opti-
MEM(R), 200µl per approach.  
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 (Note: 2x106 cells per approach were electroporated in a volume of 200µl of 
Opti-MEM(R), therefore if you had 6 approaches (12x106 cells), the pellet 
was resuspended in 1200µl Opti-MEM(R) (6 x 200µl), but to counteract the 
pipetting errors, 220µl per approach were used) 
 200µl of the cell suspension was transferred into a sterile 15mL tube and 
mixed with the appropriate amount of siRNA (for example: if final 
concentration was 400nM, 4µl of siRNA (20µM stock) were added to 200µl 
of  Opti-MEM(R)) 
 The mixture was gently vortexed and transferred into an ice cold 
electroporation cuvette 
 Each approach was electroporated with 300V and 150µF 
 The actual Volts and the timeconstant (msec) was noted after each impulse 
 Immediately after electroporation the cells were mixed with 2mL prewarmed 
1x proliferation medium and transferred to a 6well plate (1x106 cells/mL) 
 24h after the electroporation a total media change was performed                                         
 
 
2.3.1 Different siRNAs used for electroporation 
 
To ensure that the experimental outcome is true and reproducible, it is 
recommended to use at least 3 types of control samples in every electroporation 
experiment:: a positive control, a negative control and an untreated control. 
Positive controls show the efficiency of siRNA delivery into the cells and negative 
controls distinguish sequence-specific silencing from non-specific effects. 
Untreated samples determine the level of cell viability.  
 
 
Positive controls: Lamin A/C, GAPDH, FITC and Cell Death siRNA 
 
 Lamin A/C: (siGLO Lamin A/C Control siRNA, Dharmacon(R)) 
Lamin A/C- and GAPDH- siRNAs are positive silencing controls for human cells. 
Lamins are nuclear filament-type proteins, which are involved in the nuclear 
stability and chromatin structure (Tulac, Dosiou et al. 2004). 
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 GAPDH:   (StealthTM RNAi GAPDH Positive Control, Invitrogen) 
GAPDH (Glyceraldehyde 3-phosohate dehydrogenase) is an enzyme involved in 
glycolysis and serves to break down glucose for energy and carbon molecules. 
As Lamin A/C and GAPDH are non-essential in the cells, the knock-down of Lamin 
A/C or GAPDH does not induce any effects in the cells and their knock-down 
should therefore not affect cell viability or result in any other phenotype. This 
makes the Lamin AC- siRNA and the GAPDH- siRNA to a good positive control in 
experiments with siRNA-mediated knock-down.  
 
 
 FITC:   (BLOCK-ITTM Fluorescent Oligo, Invitrogen) 
The BLOCK-iT TM Fluorescent Oligo is a fluorescein-labeled double-stranded 
RNA duplex with the same length and charge as a standard siRNA. The sequence 
of the FITC siRNA is not homologous to any known gene and is therefore a non-
silencing oligonucelotide, which is not inducing any knock-down in the cells. It can 
be used as a control for the transfection efficiency, because due to the 
fluorescence signal of FITC, the transfection efficiency can be analyzed by flow 
cytometry (FACS). The fluorescent signal is localized in the nucleus and is 
therefore a signal for efficient uptake. The higher the fluorescent signal is, the 
higher also the transfection efficiency.  
 
 
 Cell Death control: (AllStars Hs Cell Death Control siRNA, QIAGEN) 
AllStars Hs Cell Death Control siRNA is a mix of siRNAs targeting human genes 
that are essential for cell survival. Knock-down of these genes induces cell death. 
Therefore this siRNA mix can be used in every electroporation as a positive 
control and as a control for transfection efficiency. 24h to 96h after electroporation 
the transfected cells undergo apoptosis, therefore the transfection efficiency can 
be estimated by simply observing the cells under the microscope or in the CASY 
cell analyzer, without to make time-consuming FACS analysis. 
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Negative controls: Low, med and high GC-siRNAs 
 
 Low-, med- and high- GC: (StealthTM RNAi Negative Control, Invitrogen) 
StealthTM RNAi Negative Control siRNAs serve as a negative control for the RNAi 
response. For each electroporation a control siRNA with a similar GC content as 
the target siRNA was used. Thereby it could be shown that the effects of the 
knock-downs were specific and not just induced by the uptake of an unspecific 
siRNA oligo. 
 
Low GC: (StealthTM RNAi Negative Control, Invitrogen)     →  36% GC-content 
Med GC: (StealthTM RNAi Negative Control, Invitrogen)     →  48% GC-content 
High GC: (StealthTM RNAi Negative Control, Invitrogen)     →  68% GC-content 
 
siRNAs for the Glucocorticoid-Receptor targets: 
 
 RAF-1: (Invitrogen, validated) 
Raf-1-1   GGA GUA ACA UCA GAC AAC UCU UAU U 
Raf-1-2   AAU AAG AGU UGU CUG AUG UUA CUC C 
 
 Tis11d: (Invitrogen, non validated) 
Tis11d-1: forward:  5’ CCG CCU UCU ACG AUG UCG ACU UCU U 3’ 
  reverse:  5’ AAG AAG UCG ACA UCG UAG AAG GCG G 3’ 
 
Tis11d-2: forward: 5’ ACC UGA ACA ACA UGC UGG ACA AGA A 3’ 
  reverse: 5’ UUC UUG UCC AGC AUG UUG UUC AGG U 3’ 
 
Tis11d-3 forward: 5’ CGC ACC UUU CAU ACC AUC GGC UUC U 3’ 
  reverse: 5’ AGA AGC CGA UGG UAU GAA AGG UGC G 3’ 
 
 
 Fkbp51 : (Invitrogen, non validated) 
Fkbp51-1: forward: 5’ ACC AAA GCU GUU GAA UGC UGU GAC A 3’ 
  reverse: 5’ UGU CAC AGC AUU CAA CAG CUU UGG U 3’ 
 
Fkbp51-2: forward: 5’ CCA GUC AUG AUA GAA AUG AAC CAU U 3’ 
  reverse: 5’ AAU GGU UCA UUU CUA UCA UGA CUG G 3’ 
 
Fkbp51-3: forward: 5’ GGA UGC CAA GGA AGA GGC CAA UAA A 3’ 
  reverse: 5’ UUU AUU GGC CUC UUC CUU GGC AUC C3’ 
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2.4 Cell Isolation Kits 
 
 
2.4.1 Dead Cell Removal 
 
After electroporation, dead cells can be romoved from the cell suspension by the 
“MACS (R) Dead Cell Removal Kit” (Miltenyi Biotec). Dead Cell Removal 
MicroBeads recognize Annexin-V in the plasma membrane of apoptotic and dead 
cells. Using antibodies against Annexin-V, dead and early apoptoic cells can be 
romoved from the cell suspension.  
 
 1x Binding Buffer was prepared by dilution of 20x Binding Buffer Stock 
solution (250µl of 20x Binding Buffer was diluted with 4,75mL of sterile H2O) 
 Cell suspension was collected and centrifuged for 5minutes at 300xg 
 Supernatant was removed completely and cell pellet was resuspended in 
100µl of Dead Cell Removal MicroBeads per approximately 107 cells (for 
fewer cells same volume is used)  
 Mixed well and incubated for 15minutes at room temperature (Note: During 
this incubation time the magnetically labeled Dead Cell Removal 
MicroBeads bind to the dead and apoptotic cells) 
 The Column was placed in magnetic field and prepared by rinsing with 
500µl of 1x Binding Buffer 
 The Cell suspension was applied onto the column (500-1000µl)  
 Rinse the column 4 x with 500µl of 1x Binding Buffer 
 The magnetically labeled dead cells are retained in the column, while the 
unlabeled living cells pass through and are collected in a sterile 15mL 
plastic tube. 
 50µl of collected cell suspension was taken for cell count by the CASY cell 
analyzer 
 Centrifuged 1200 rpm (250xg) for 5minutes 
 Cell pellet was resuspended in appropriate 1x proliferation factor medium to 
reach a cell density of 1x106 cells/mL.  
 Note: Approximately half of the cells are lost during this process 
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2.4.2 CD34+ Isolation  
 
Out of mononuclear cells the CD34+ cells can be isolated by the “CD34 
MicroBead Kit” (MACS Miltenyi Biotec). The CD34 antigen is a transmembrane 
glycoprotein expressed on human hematopoietic stem and progenitor cells. The 
CD34 MicroBead Kit contains MicroBeads, which are directly conjugated to CD34 
antibodies. Thereby CD34-expressing hematopoietic cells can be magnetically 
labelled and isolated by applying them on a column within a magnetic field, 
whereby the magnetically labeled CD34+ cells are retained. When column is 
placed out of the magnetic field, the bound CD34+ cells can be eluted: 
 
 Mononuclear cells are isolated or cell aliquots are thawed and resuspended 
in 10mL RPMI-medium containing 2mM EDTA 
 Cell suspension is centrifuged for 5 minutes with 250 x g (1200 rpm) 
 Supernatant is removed completely and cell pellet is washed with 10mL 
PBS+ 2mM EDTA 
 Centrifuge for 5 minutes with 250 x g (1200rpm) 
 Supernatant is removed completely and cell pellet is resuspended in 300µl 
of buffer (per 108 cells) (BUFFER: PBS+0,5% bobine serum albumin (BSA) 
and 2mM EDTA) 
 Add 100 µl of FcR Blocking Reagent for up to 108 total cells 
 100µl of CD34 MicroBeads (for up to 108 total cells) are added, mixed well 
and incubated for 30minutes at 4°C (Note: CD34+ cells are bound to the 
magnetically labeled MicroBeads) 
 Cells were washed by adding 5-10mL of buffer and centrifuged at 300xg for 
10minutes, the cell pellet was resuspended in 500µl of buffer for 108 total 
cells 
 The column was placed in the magnetic field and prepared by rising with 
500µl of buffer 
 Cell suspension was applied on the column, and the column was washed 3 
x with 500µl of buffer. The flow-through can be collected (Note: the 
magnetically labeled Lin+ cells (CD34+) are retained within the column 
while the unlabeled Lin- cells pass through) 
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 Column is removed from the magnetic field and placed on a sterile 15mL 
plastic tube 
 1mL of buffer was pipetted onto the column and the the magnetically 
labeled CD34+ cells (now not longer bound within the magnetic field) are 
eluted by pushing the plunger into the column 
 10mL of PBS are added, cell suspension was counted and centrifuged 
1200 rpm (250xg) for 5minutes, cell pellet was resuspended in appropriate 
1x proliferation factor medium to reach a cell density of 1x106 cells/mL.  
 By FACS analysis the purity of CD34+ cells can be measured 
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2.5 Working with Proteins 
 
To analyse changes on the protein level, Western blot analysis was performed.  
 
 between 5x105 to 1x106 cells were transferred into an Eppendorf tube  
 centrifuged for 5minutes at 250xg 
  the supernatant was completely removed 
  the cell pellet was washed once with 1ml PBS  
 centrifuged for 5min at 250xg 
 The washed cell pellet was shock-frozen in liquid nitrogen and stored at -
80°C.  
 
 
2.5.1 Protein Isolation 
 
The pellet was lysed with 110µl to 130µl Tx100-Lysisbuffer depending on it’s size. 
The lysis steps were as follows: 
 
→ mixing well by vortexing (for ca. 30sec) 
→ incubating on ice for 10minutes 
→ mixing well by vortexing (for ca. 30sec) 
→ incubating on ice for 10minutes 
 
 
Tx100 Lysisbuffer:   150mM NaCl 
 10mM Tris pH 7,4 
 1% Triton X-100 
 0,1%SDS 
 1mM EDTA 
 
Before use to 10mL of the Tx100 Lysisbuffer there was added: 
 1 pastille of PhosSTOP Phosphatase inhibitor cocktail (ROCHE) 
 1 pastille of cOmplete Mini, EDTA free, Protease inhibitor coctail (ROCHE) 
 5µl of Okadaic Acid (1:2000) (stock: 100µM) 
 
After shaking 1mL aliquots of the Lysisbuffer were stored at -80°C.  
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Protein concentration was measured by the Pierce(R) BCA Protein Assay Kit 
(Thermo Scientific).  
 Therefore the BCA protein-assay-reagent A was diluted 1:50 with BCA 
protein-assay-reagent B.  
 Six dilutions of BSA were measured together with the samples to determine 
the standard curve (2mg/ml, 1mg/ml, 0,5mg/ml, 0,2mg/ml, 0,1mg/ml and 
0,05mg/ml).  
 200µl of the BCA-Protein-Assay-Reagent-mix were added to 10µl of each of 
the standard-concentrations (in triplicates) on a 96-well plate. 
 
This mixture was incubated at 37°C for 30minutes, where its colour turned from 
green to dark- or light- violett depending on the protein-concentration. The 
absorbance was measured photometrically at 650nm. The protein-concentrations 
of the samples were computed with the help of the BSA standard curve.  
 
The isolated proteins were mixed with 5x protein loading buffer and incubated at 
95°C for 5minutes to denature the proteins further sonificated at the ultrasonic- 
bath for 20minutes to shear the DNA in total cell lysates.  
 
10µg to 20µg of the isolated proteins were loaded on a polyacrylamid gel for 
Western Blot analysis.  
 
2.5.2 Western Blot analysis 
 
Western Blot analysis is a standard method to determine the expression of various 
proteins by using specific antibodies; the method consists basically of the following 
steps: 
 
 After protein-isolation the proteins were seperated by denaturing 
polyacrylamide gel electrophoresis (SDS-PAGE) 
 The separated proteins were transferred from the polyacrylamide gel to a 
PVDF-membrane (Millipore) 
 The proteins bound to the membrane were analyzed with specific 
antibodies 
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SDS gel electrophoresis 
 
SDS PAGE is a classical method for separation of proteins in an electric field 
according to the molecular weight. SDS-polyacrylamide gel consists of two parts: a 
lower part (separating gel), where the proteins are seperated, and an upper part 
(stacking gel), where the proteins are accumulated before entering the separating 
gel.  
 
Solutions for SDS-PAGE 
 
 
5x sample buffer:   0,1M Tris-Cl  
5% SDS 
17% Glycerol 
5% mercaptoethanol 
1/100 volume of a 0,5% bromophenolblue   
solution 
 
Separating Gel-buffer:   36,34 g Tris 
4mL 20% SDS 
150mL A.d. pH 8,8 
add A.d. to reach a volume of 200mL 
 
Stacking Gel-buffer:  6,08 g Tris 
     2mL 20% SDS 
     50mL A.d. pH 6,8 
add A.d. to reach a volume of 100mL 
 
 
10x Running Buffer for 1000mL:  1,9 M Glycin (142,6g) 
     250 mM Tris-Base (30,3g) 
1% SDS (50mL) 
 
1x Running Buffer for 1000mL : 100mL 10x Running Buffer 
     900mL A.d 
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10x Blotting Buffer for 1000mL:  1,9 M Glycin (142,6g) 
      250 mM Tris-Base (30,3g) 
      10% Methanol (100mL) 
 
 
1x Blotting Buffer for 1000mL:  100mL 10x Blotting Buffer 
      200mL Methanol 
      700mL A.d. 
 
 
10x TBS Buffer for 1000mL:  1,5 M NaCl 
      100mM Tris, pH 7,4 or 8 
 
 
1x TBS-T Buffer for 100mL:  100mL 10x TBS Buffer 
      900mL A.d. 
      0,05 % Tween 20 (500µl)  
 
 
Stripping Buffer:    2% SDS 
      62,5 mM Tris, pH 6,8 
to 50mL Stripping Buffer add 390µl ß-
Mercaptoethanol (prepare always fresh)
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Two 10% polyacrylamid-separating gels were prepared as follows: 
 
milliQ water      8,97 mL 
Polyacrylamid (30%)    7,53 mL 
Separating Gel-buffer        5,7 mL 
APS (10%) (Ammonium-peroxidisulfate)    336µl 
TEMED (Tetramethylethylendiamine)       15µl  
 
Two stacking gels were prepared as follows: 
 
milliQ water               3 mL 
Polyacrylamid (30%)                 0,9 mL 
Stacking Gel-buffer              1,33 mL 
APS (10%)                52,5 µl 
TEMED           7,5 µl  
 
First, the components of the running gel were mixed carefully, then poured and 
Isopropanol was added on the top to eliminate air-bubbles. 
After the gel polymerized, the isopropanol was removed and the stacking gel 
mixture was poured on the running gel (a comb was placed immediately between 
the two glass plates). 
Depending on the size of the respecitve proteins, the concentration of acrylamide 
of the running gel can be decreased or increased. For proteins between 40kD and 
80kD like for example Lamin A/C, Gapdh, Raf-1, Tis11d, FKBP51 a 10% gel were 
used and if we wanted to analyse smaller protein-fragments of for example 
Caspase-3, we used a 12% gel.  
Depending on the amount of isolated proteins 10µg of protein and 5µl of the 
marker (PageRuler prestained protein ladder, Fermentas) were loaded. The 
electrophoresis was performed in the 1x PAGE-Running buffer and the proteins 
were separated with: 
 
50Volt , 100mA, 50W:       till proteins run through the stacking in the separating gel 
70Volt, 100mA, 50W:        till the proteins run to the middle of the separating gel 
100-130V, 100mA, 50W:  till the proteins run to the end of the separating gel 
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Western transfer 
The proteins were transferred from the polyacrylamid gel to the PVDF-membrane 
(Millipore), which is highly hydrophobic and therefore first had to be activated by 
incubation in methanol for 10minutes.  
 
The transfer was performed in blotting buffer for: 
 
→ 1,5hour, 400mA, 100V, 50W, on ice  
→ 15-16hours (over night), 90mA, 30-35V, 50W, at +4°C 
 
Antibody incubation 
 The membrane was first stained for 5minutes with Ponceau S, which is an 
unspecific protein stain, thereby blotting-problems (like airbubbles) or 
unequal loading can be assessed immediately. 
 The dye was washed away at first with water and then with TBS-T buffer 
until the membrane was completely clear from the Ponceau staining.  
 The membrane was blocked for 1h at room temperature with 5% dry low fat 
milk powder in 1xTBS-T to block unspecific antibody binding to the PVDF-
membrane. 
  Then the membrane was washed 3times with TBS-T for 5minutes.  
 The first antibody was diluted to the appropriate concentration and 
depending on the antibody it was either incubated over night at 4°C or for 
1hour at room temperature with the membrane.  
 After the first antibody-incubation the membrane was washed again 3times 
with 10mL TBS-T for 10-15 minutes each and then incubated with the 
appropriate secundary antibody diluted in TBS-T for 1hour at room 
temperature.  
 This was followed by another three washing steps with 1x TBS-T.  
 The membrane was transferred into a transparent plastic foil and 400-800µl 
of equal amounts of the chemoluminescence ECL solution 1 and 2 (Thermo 
Scientific) was distributed eaqually over the membrane.  
 A light sensitive X-ray film (GE Healthcare) was put in an exposure box 
together with the membrane, exposed for appropriate time (from 20sec- 
20minutes, depending on the intensity of the signal) and then developed.  
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In the presented work the following antibodies (in the indicated dilutions) were  
used: 
  
 
All of the membranes were blocked always with 5% dry low fat milk and washed 
with TBS-T. 
 
First antibody Company Second antibody 
Lamin A/C  
(1:200, in TBS-T) 
Santa Cruz 
Biotech. 
Mouse (1:25.000, in TBS-T) 
Tis11d 
 (1:200, 1%BSA in TBS-T) 
Santa Cruz 
Biotech. 
Rabbit (1:20.000, in TBS-T) 
Fkbp51  
(1:1000, 1%BSA in TBS-T) 
Santa Cruz 
Biotech. 
Goat (1:30.000, in TBS-T) 
Gapdh  
(1:1000, in TBS-T) 
Cell Signalling Rabbit (1:20.000, in TBS-T) 
Raf-1  
(1:1000,1%BSA in TBS-T) 
Cell Signalling Mouse (1:25.000, in TBS-T) 
Caspase3 
(1:1000,5%milk in TBS-T) 
Cell Signalling Rabbit (1:20.000, in TBS-T) 
pERK 
(1:1000, 1%BSA in TBS-T) 
Cell Signalling  Rabbit (1:20.000, in TBS-T) 
panERK  
(1:5000, 1%BSA in TBS-T) 
BD Biosciences Mouse (1:25.000, in TBS-T) 
Actin   
(1:10.000 in TBS-T) 
Cell Signalling Mouse (1:25.000, in TBS-T) 
pIKK α/ß  
(1:1000, 1%BSA in TBS-T) 
Cell Signalling (NF-
kappa B Pathway 
sampler Kit 
Rabbit (1:2000 in TBS-T,of KIT) 
pNFKB  
(1:1000, 1%BSA in TBS-T) 
Cell Signalling (NF-
kappa B Pathway 
sampler Kit 
Rabbit (1:2000 in TBS-T,of KIT) 
NFKB  
(1:1000, 1%BSA in TBS-T) 
Cell Signalling (NF-
kappa B Pathway 
sampler Kit 
Rabbit (1:2000 in TBS-T,of KIT) 
pIKB-α  
(1:1000,  1%BSA in TBS-T) 
Cell Signalling (NF-
kappa B Pathway 
sampler Kit 
Rabbit(1:2000 in TBS-T,of KIT) 
IKB-α  
(1:800,  1%BSA in TBS-T) 
Cell Signalling (NF-
kappa B Pathway 
sampler Kit 
Mouse(1:2000 in TBS-T,of KIT) 
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2.6 Working with RNA  
 
 
To analyse the knock-down efficiency on mRNA-level we performed Q-PCR, 
therefore first the RNA was isolated, reverse transcribed into cDNA and then a 
Real-Time PCR was done. 
 
 
2.6.1 RNA Isolation 
 
The RNA extraction was performed with the “RNA-Easy Mini Kit 250” (Qiagen), the 
extraction of the RNA was performed according to the protocol provided with the 
kit. The amount of isolated RNA was analysed with the nanodrop-method 
photometer. 
 
2.6.2 cDNA synthesis 
The cDNA synthesis was performed with the “First Strand cDNA Synthesis Kit” 
(Fermentas), for each cDNA synthesis 500ng of total RNA were reverse 
transcribed into cDNA as described:  
 
Total RNA                 500ng (1 to 11µl depending on the RNA concentation) 
Random hexamer primer                1µl 
DEPC-treated water                to 12µl  
 
Total volume                 12µl 
 
After adding all of the components, the mixture was vortexed, spinned down and 
incubated for 5minutes at 65°C and then on ice. To this mixture 8µl of the 
Mastermix were added to reach a total volume of 20µl. 
 
Mastermix:  
5x reaction buffer          4µl 
RiboLockTM RNase Inhibitor (20 U/µl)  1µl 
10mM dNTP mix     2µl   
M-MuLV Reverse Transcriptase (20 U/µl)         1µl__        
            
Total Volume     20µl 
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The mixture then was incubated for 5minutes at 25°C and then at 42°C for 
60minutes. To terminate the reaction the mixture was heated at 70°C for 5minutes. 
 
 
2.6.3 Real Time PCR (Q-PCR) 
 
The amplified cDNA was diluted 1:1 with RNAse free water (20µl cDNA+20µl 
RNAse free water). The Real Time PCR was done in triplicates, the PCR mixture 
included: 
 
Diluted cDNA (1:1)        2 µl 
2x Power SYBR Green Master Mix*    5 µl 
forward primer (10pmol)     0,5 µl 
reverse primer (10pmol)     0,5 µl 
RNAse free water            ____2 µl____ 
Total volume     10 µl 
 
*(Applied Biosystems) 
 
 
To determine the optimal Annealing Temperature: (G+C) x 4°C + (A+T) x 2°C – 5°C 
(calculate the mean value of the 2 primers). 
 
 
 
RT-PCR conditions: 
 
Stages Temperature 
 
Time 
 
 
Stage 1 
 
50°C 2 minutes 
 
Stage 2 
 
95°C 10 minutes 
 
Stage 3 (40 cycles) 
 
95°C 15 sec 
 
End 
 
60°C 1 minute 
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In the present study following primer pairs were used for the Q-PCR : 
 
 
 
 LAMIN A/C: (SIGMA) 
LAMIN A/C: forward: 5’ GAC TCA GTA GCC AAG GAG CG 3’ 
  reverse: 5’ GCA GCT ATC AGG TCA CCC TC3’ 
 
 
 
 GAPDH :  (SIGMA) 
GAPDH: forward: 5’ CCT GTT CGA CAG TCA GCC G 3’ 
  reverse: 5’ CGA CCA AAT CCG TTG ACT CC3’ 
 
 
 
 Raf-1 : (SIGMA) 
Raf-1:  forward: 5’ CTG GGA CTC CAC TAT CAC CA 3’ 
  reverse: 5’ GCA CTG TAG CAC CAA AGT AC 3’ 
 
 
 
 Tis11d : (SIGMA) 
Tis11d: forward: 5’ TGT GCA AGA CAG AGA GAA ATC CC 3’ 
  reverse: 5’ GAG TGC CGT CGG AGG AAT C 3’ 
 
 
 
 Fkbp51 : (SIGMA) 
Fkbp51: forward: 5’ CCG CAA GTT CTA CTC CAT CC 3’ 
  reverse: 5’ CCT TGG CTG ACT CAA ACT CG3’ 
 
 
 
 hCSNK1d : (SIGMA) (houskeeper) 
hCSNK1d: forward: 5’ AGG AGA AGA GGT TGC CAT CAA G 3’ 
  reverse: 5’ TCC ATC ACC ATG ACG TTG TAG TC 3’ 
 
 
 
 ß-2-Microglobulin (B2M): (SIGMA) (housekeeper)  
B2M:  forward: 5’ GGG TTT CAT CCA TCC GAC ATT G 3’ 
  reverse: 5’ TGG TTC ACA CGG CAG GCA TAC C3’ 
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3. RESULTS 
 
3.1 Isolation and outgrowth of mononuclear cells from cord blood 
 
All of our experiments were performed with human erythroid progenitor cells. 
Therefore mononuclear cells were isolated from human umbilical cord blood 
according the protocols in Materials and Methods and as demonstrated in figure  
15 below:  
 
 
 
 
 
 
 
 
 
 
 
 
 
After isolation, mononuclear cells were expanded under defined culture conditions 
to erythroid progenitor cells (hEPCs). Figure 16 shows the outgrowth of EPCs from 
mononuclear cells. Therefore daily cell aliquots of mononuclear cells were 
cytocentrifuged onto glass slides and stained by histological stainings (as 
described in Materials and Methods), also cell counts were performed every day 
by the CASY-cell-analyzer.   
At d0 the cytospins showed mainly a heterogeneous cell suspension with different 
types of mononuclear cells, whereas at d10 the cell suspension was more 
homogeneous due to the accumulated progenitor cells. Also the CASY-profiles, 
shown in the right panel of figure 16, changed, they are giving you informations of 
the cell-count and the cell-size. While at d0 the peak was around 7µm, at d10 a 
Figure 15: Isolation of mononuclear cells from human cord blood through 
a Ficoll-gradient (picture taken from: Ernst Müllner) 
 
Expansion 
in culture 
Maturation 
in culture / 
in vivo 
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clear shift towards bigger size (around 10µm) was observed, which indicates that 
the smaller already differentiated cells (erythrocytes, granulocytes, macrophages) 
died off and the undifferentiated bigger EPCs accumulated. Therefore we could 
show that around d10 out of the heterogeneous culture at d0, a homogeneous 
culture of erythroid progenitors (hEPCs) grew out. The cells were kept in culture till 
around d12 to d14, when they were ready for experiments.  
 
 
 
 
 
hematological 
staining (x40): 
CASY- profile: Light-microscope 
(x40): 
+   DEX 
     EPO 
     SCF 
     IGF-1 
     Lipids 
Figure 16: Outgrowth of hEPCs from mononuclear cells:  
After isolation from human umbilical cord blood, mononuclear cells are expanded under 
defined culture conditions to erythroid progenitor cells (hEPC’s) in serum free StemSpan 
medium supplemented with Epo (2U/mL), SCF (100ng/mL), DEX (10-6M), IGF-1 
(40ng/mL) and a cholesterol-rich lipid mix (20µg/mL). 
Here are shown pictures of the cell suspension at d0, immediately after isolation of the 
mononuclear cells and at d10 after cultivation: the picture on the left is showing an 
exposure with the light-microscope (x40), in the picture in the middle are demonstrated 
the cytospins(x40) and the picture on the right panel shows the Casy-profiles. 
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3.2 Optimization of the electroporation method 
 
In order to be able to downregulate specific glucocorticoid target genes, the 
settings for transfection of siRNAs into the cells by electroporation had to be 
optimized. Several variables can be changed in order to determine the ideal 
electroporation conditions. Every cell type requires different electroporation 
settings, which have to be determined empirically. The pulse length, temperature, 
cell density, voltage- and capacity- settings and the siRNA- concentration are all 
critical parameteres, which have to be optimized at the beginning to determine the 
best conditions to achieve a high knock-down efficiency, a high cell viability and a 
high transfection efficiency at the same time.  
 
 
3.2.1 Best Voltage and Capacity settings 
 
The voltage- and capacity- settings critically determine cell survival and 
transfection rate. If the voltage-settings (field strength: V/cm) are high enough, it 
induces permeabilization of the membrane and allows an uptake of molecules 
from the surrounding media (Jordan et al., 2008). This event is depending on 
several factors, like cell diameter and temperature. In general smaller cells require 
higher voltages than larger cells. But higher voltage-settings can also promote cell 
damage. Therefore it is essential to determine the best settings, by which a high 
knock-down efficiency and also a high cell viability are achieved at the same time.  
 
For this purpose 2x106 cells were electroporated with a non- silencing fluoresently 
labeled siRNA (FITC) with different voltage- and capacity- settings. The 
transfection efficiency and cell viability was then analysed by Flow Cytometry. The 
results of the obtained FACS-data are shown in figure 17.  Our data revealed that 
the higher the voltage- and capacity settings were, the higher the transfection- 
efficiency was. When cells were electroporated for example with 950µF or with 
400V, over 90% of the hEPCs were transfected, but just 20% of the cells survived 
the procedure. And at the same time when the settings were below 300V or 150µF, 
cell viability was over 95%, but just 25% of the cells were transfected.  
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Best Voltage settings:  
 
 
 
 
 
 
 
    
   dead cells 
   transfected cells 
 
 
Best Capacity settings: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From this data we concluded that 300V and 150µF resulted to be the best settings 
to achieve a high transfection efficiency (over 60%) and also a high cell viability 
(over 90%) at the same time. Note: Transfection efficiency is slightly under-
estimated by flow cytometric analysis because the signal intensity for the FITC-
labeled oligo is very low, and therefore, the peaks of control and transfected cells 
always showed an overlap. When the cells were transfected with FITC-siRNA by 
electroporation, transfection efficiency was always higher than 75%. 
Applied Voltage settings:  
 
1: 200V, 150µF 
2: 250V, 150µF  
3: 300V, 150µF 
4: 350V, 150µF 
5: 400V, 150µF 
 
Figure 17: Best voltage and capacity settings 
 2x106 cells were electroporated with a non- silencing fluoresently labeled siRNA (FITC) 
with different voltage- and capacity- settings. The transfection efficiency and cell viability 
was then analyzed by Flow Cytometry (FACS).  
 
Applied Capacity settings:  
 
1: 25µF,  300V 
2: 50µF,  300V 
3:100µF, 300V 
4: 200µF, 300V 
5: 400µF, 300V 
6: 600µF, 300V 
7: 950µF, 300V 
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3.2.2 Best siRNA- concentration 
 
Transfection of siRNA can result in off-target effects, in which siRNAs do not just 
induce the degradation of homologous mRNAs, but they can affect also the 
expression of partially homologous or even non homologous genes. Those off-
target effects can be avoided by using lowest effective siRNA concentrations. But 
on the other side, if siRNA-concentration is too low, knock-down may be 
undetectable. To find out the lowest siRNA- concentration, by which off-target 
effects are reduced and at the same time a high a knock-down efficiency and a 
low cytotoxicity is still guaranteed, hEPCs (d15) were electroprated with different 
amounts of LAMIN A/C- siRNA (siRNA concentration varies from 100nM to 1,6µM), 
one approach electroporated without siRNA and one approach not electroporated 
at all served as a control.  
 
(A)       (B) 
 
 
 
 
 
 
 
(C) 
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Figure 18: Best siRNA-
concentration 
 
(A) LAMINA/C knock-down was 
analysed 48h after electroporation 
by Western blot analysis. (B) The 
knock-down efficiency was 
quantified relative to beta-actin.  
(C) Cell viability was measured 48h 
after the electroporation by FACS- 
analysis. 
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As shown in figure 18 the knock-down efficiency was analysed 48h after the 
electroporation by Westernblotting and quantified relative to beta-actin. The cell 
viability was measured by FACS-analysis. Our data revealed that a siRNA- 
concentration of 400nM seemed to be sufficient to achieve a knock-down 
efficiency of 75% and a cell viability of approximately 80% (48h after the 
electroporation).  
 
 
3.2.3 Stability and time-course of the knock-down 
 
Electroporation with siRNAs is resulting in a transient not stable knock-down. If 
cells proliferate the amount of the uptaken siRNA in the cytoplasm decreases, 
which leads again to an increase of the expression level after a certain periode of 
time (72h to 96h). To determine the stability of the knock-down after the 
electroporation, 2x106 cells (d15) were electroporated with 2 different siRNAs: 
LAMIN A/C- and GAPDH-siRNA (siRNA- concentration: 100nM and 400nM). 
Knock-down efficiency and cell viability was analysed 24h to 96h after the 
electroporation (by Western Blotting, Q-PCR and FACS analysis). One approach 
electroporated without siRNA and one approach electroporated with the non-
coding FITC-siRNA served as a control. 
 
 
Cell viability 24h to 96h after electroporation 
 
As shown in the upper panel of figure 19 the cell viability seemed not to be 
affected by the siRNA- concentration or the type of siRNA, as cell viability didn’t 
differ between the approaches electroporated with a concentration of 100nM or 
400nM, nor we could detect differences in cell viability, when cells were 
electroporated with different types of siRNAs. Cell viability was always around 90% 
in all of the appraoches, even 96h after the electroporation.  
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(A)                  Cell viability 24h to 96h after electroporation 
 
 
 
 
 
 
 
 
 
 
 
 
 
(B)   Knock-down: 24h     Knock-down: 48h 
 
 
 
 
 
 
Knock-down: 72h    Knock-down: 96h  
 
 
 
 
 
(C)          Q-PCR:  Lamin-AC knock-down         Q-PCR: Gapdh knock-down 
 
 
 
 FITC
   1
0
0
  
Lamin AC 
Actin 
Gapdh 
n
o
 siR
n
a 
Lam
in
  1
0
0
 
Lam
in
  4
0
0
 
G
ap
d
h
 1
0
0
 
G
ap
d
h
 4
0
0
 
FITC
   4
0
0
  
FITC
    4
0
0
  
FITC
    1
0
0
  
G
ap
d
h
 4
0
0
 
G
ap
d
h
 1
0
0
 
Lam
in
  4
0
0
 
Lam
in
  1
0
0
 
n
o
 siR
n
a 
Lamin AC 
Actin 
Gapdh 
 
0
10
20
30
40
50
60
70
80
90
100
24h 48h 72h 96h
%
 P
I n
eg
at
iv
e 
ce
lls
no siRNA
Lamin 100nM
Lamin 400nM
Gapdh 100nM 
Gapdh 400nM
FITC 100nM
FITC 400nM
Figure 19: Time-course of the knock-down 
2x106 cells (d15) were electroporated with 2 different siRNAs: LAMIN A/C- and GAPDH-siRNA at 
a concentration of 100nM and 400nM. One approach electroporated without siRNA and one 
approach electroporated with the non-coding FITC-siRNA served as a control. (A) 24h to 96h 
after electroporation the cell viability was analysed by flow cytometry, whereas the knock-down 
was analysed on protein-level by Westernblot-analysis (B) and on mRNA-level by Q-PCR 24h to 
96h (C).  
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LAMIN A/C knock-down 
The knock-down efficiency on protein level was analysed by Westernblotting and 
on mRNA-level by Q-PCR 24h to 96h after the electroporation. We could show 
that when the siRNA- concentration was 400nM, the LAMIN A/C- knock-down on 
protein-level was stable until 96h after electroporation, whereas at a concentration 
of 100nM, the expression increased again after 72h (see figure 19 B) and C)).  
This data reveal that the used siRNA- concentration might influence the knock-
down stability. The higher the siRNA- concentration, the higher the stability of the 
knock-down might be.The highest down-regulation of LAMIN A/C on protein-level 
could be achieved 72h after electroporation and on mRNA-level after 24h.   
 
GAPDH- knock-down 
In this first experiment the GAPDH- levels couldn’t be reduced as much as the 
Lamin- A/C levels, because the highest knock-down on protein-level was achieved 
just 96h after the electroporation, while on mRNA level the highest down-
regulation seemed to be achieved after 48h.  
The GAPDH-siRNA was used in all of our following electroporations as a positive 
control and as shown in figure 20 with the optimized settings we were able to 
reduce the GAPDH- expression on mRNA- level by over 80% after 48h (data of 4 
independent experiments and 3 different hEPC cultures isolated from 3 different 
cord-blood samples) and on protein- level up to 80% after 72h.  
 
(A) Knock-down on mRNA level (48h):        (B) Knock-down on protein-level (72h): 
 
 
 
 
 
 
 
 
 
 
 
0
20
40
60
80
100
low GC Gapdh
Figure 20: Gapdh knock-down 48h after electroporation 
(A) 48h after electroporation the GAPDH- expression on mRNA-level could be reduced by 
over 80% in 4 independent experiments (analysed by Q-PCR) and on protein level (B) up 
to 80% 72h after electroporation (analysed by Westernblotting). 
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3.2.4 Best time constant and electroporation volume 
 
Other important paramenters which have to be considered for a successful 
electroporation are pulse length and temperature. The pulse applied to the cells 
can be a square or an exponential wave (Jordan et al., 2008). The time constant is 
defined as the duration of the decay of the exponential wave, it is the product of 
the capacitance settings and the resistance of the sample (resistance is 
dependend on the ionic composition of the electroporation buffer). Therefore the 
higher the capacitance settings, the higher also the time-constant and the lower 
the cell viability was.  
In our experiments, the cuvettes were always placed on ice before the 
electroporation, as we detected that the lower the temperature of the 
electroporation cuvettes was, the higher also the time-constant was. We observed 
that a time-constant around 10 msec to 13 msec was optimal to achieve a high 
viability and a high knock-down efficiency.  
We always electroporated 2x106 cells in a volume of 200µl and we found that also 
the electroporated volume seems to be a crucial factor for the knock-down 
success. If volume was higher than 200µl (for example 600µl) the time-constant 
decreased dramatically from 12msec to 3msec. This short pulse was definitely too 
short to allow the siRNA to enter the cells, therefore also no knock-down could be 
achieved (data not shown).  
 
In summary the best electroporation settings for hEPCs were:  
 
 Voltage- and capacity settings: 300V and 150µF 
 Cell density: 2x106 cells  
 sufficient siRNA concentration: 400nM 
 electroporation volume: 200µl (to ensure a time-constant around 12msec) 
 precooled electroporation cuvettes  
 low salt transfection medium (Opti-MEM (R)) 
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3.3 Raf-1: serine/threonine kinase 1 
 
To study the function of Raf-1 in human EPCs, downregulation of Raf-1 was 
performed with two validated Raf-1- siRNAs (Raf-1-1 and Raf-1-2). For this 
experiment three different negative controls were used: One approach not 
electroprated (no elpo), one approach electroporated without siRNA (no oligo) and 
one approach electroporated with the non-coding siRNA (low GC-siRNA). To 
control the electroporation efficiency, one approach was electroporated with the 
Gapdh-siRNA under the same conditions. The Gapdh-expression on protein-level 
could be reduced by over 80% (analysed by Western-Blotting 48h after 
electroporation, shown in figure 21). 
48h afer the electroporation the down-regulation of Raf-1 on protein-level was 
analysed by Western-Blotting. The Raf-1 protein- level could be reduced by over 
90% with both Raf-1 siRNAs (Raf-1-1 nd Raf-1-2), as demonstrated in figure 21 
(A). This result was obtained with both used siRNAs.  
The Raf-1 levels could be reduced not only on protein-level, but also on mRNA-
level, which was analysed by Q-PCR (shown in figure 21 (B)).  
 
 
A) Raf-1 knock-down on protein-level (48h)       
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Figure 21: Raf-1 knock-down  
2x106 cells  per approach were electroporated with 2 different Raf-1 siRNAs (Raf-1-1 and 
Raf-1-2). As a positive control the Gapdh-siRNA was used; the non-coding low GC-siRNA 
and two approaches either not electroporated (no elpo) or electroporated without siRNA 
(no oligo) served as negative controls. 48h after electroporation the downregulation was 
analysed on protein-level by Westernblot-analysis (A) and on mRNA-level by Q-PCR (B).  
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Effects of the Raf-1 knock-down  
 
As it has has been reported that Raf-1-deficient mouse erythroblasts differentiate 
much faster than the wild-type erythroblasts (Kolbus et al., 2002), we expected 
more spontaneous differentiation and a lower proliferation-rate of human EPCs 
after reduction of Raf-1. In the second round of experiments, the Raf-1 protein 
levels could be reduced by over 65% and the mRNA-levels by over 60% 48h after 
the electroporation, as demonstrated in figure 22 (B).  
The Gapdh-siRNA was used as a positive control; the non-coding low GC-siRNA 
and one approach electroporated without siRNA (no oligo) served as negative 
controls. The Gapdh-expression on protein-level could be reduced by over 85% 
(analysed by Western-Blotting after 48h, shown in figure 22 (A)). 
 
 
(A) Knock-down on protein level (48h)         (B) Knock-down on mRNA-level (48h) 
 
 
 
 
 
 
 
 
Figure 22: Raf-1 knock-down on protein- and on mRNA-level 
2x106 cells per approach were electroporated with 2 different Raf-1 siRNAs (Raf-1-1 and 
Raf-1-2). The Gapdh-siRNA was used as a positive control; the non-coding low GC-siRNA 
and one approach electroporated without siRNA (no oligo) served as negative controls. 
Knock-down has been analysed on protein level by (A) Western Blot- and on mRNA level 
by (B) Q-PCR- analysis 48h after electroporation.  
 
 
When compared to mouse EPCs, human EPCs show more spontaneous 
differentiation. Additionally the spontaneous differentiation was also increased 
when the hEPCs were cultivated at densities higher than 1x106 cells/ml.   
Thus we tried to enhance the expected effects of the Raf-1 knock-down by 
keeping the Raf-1 deficient cells at higher cell-densities.  
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As the data of our first Raf-1 knock-down experiment revealed that the highest 
knock-down of Raf-1 could be achieved 48h after the electroporation, this 
timepoint was used for seeding the electroporated cells in three different 
concentrations (in triplicates of 100µl each), the cumulative cell number was 
analysed from 48 to 120 hours after the electroporation. The three different used 
concentrations were:   
→ 1x106 cells/ml 
→ 2x106 cells/ml 
→ 4x106 cells/ml 
 
The cytospins, the Casy-counts and -profiles of different timepoints (72h to 120h) 
gave us insights of the effects of the Raf-1 downregulation.  
 
 
3.3.1 Effects of the Raf-1 knock-down on proliferation rate 
 
While we couldn’t detect significant differences in the proliferation rate at a cell 
density of 1x106 and 2x106 cells/ml, we could demonstrate that Raf-1 deficient 
cells proliferated slower compared to the cells electroporated with the lowGC-
control, when they were cultivated at a cell-density of  4x106 cells/ml.  
As demonstrated in figure 23 the highest difference between cells with reduced 
Raf-1 levels and the controls according the cumulative cell numbers, was at the 
timepoint of 96h after the electroporation. At later time points, e.g. 120hours after 
the electroporation the cell numbers of the Raf-1 approaches were again similar to 
those of the control. We didn’t analyse wheater the Raf-1 knock-down was still 
present 120h after the electroporation, so it is possible that at this timepoint the 
Raf-1 protein levels were increased again and thereby the inhibitory effects on the 
proliferation got lost.  
 
Imortantly, it should be noticed that the different approaches were not adjusted 
daily to their specific cell-concentration (1x106, 2x106 and 4x106 cells/mL), as the 
sample volume of 100µl was too small. Therefore all of the approaches (for each 
siRNA in three different concentrations in triplicates) were fed every day by simply 
adding 100µl of fresh proliferation medium.  
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Effects of the Raf-1 knock-down on proliferation rate 
 
Proliferation-rate after Raf-1 knock-down (with three different cell densities) 
 
 
 
 
 
 
 
 
 
 
 
                 
 
                   Raf-1-1-siRNA 
          
                              Raf-1-2-siRNA 
            
                   low GC siRNA 
 
   
                 
 
 
 
 
 
 
Thereby the cell-concentrations were diluted every day step by step and 120h 
after electroporoation the cell density might have been much lower than 4x106 
cells/ml. This could also explain why the effects on the proliferation were 
diminished or reverted 120h after electroporation. 
 
Figure 23: Effects of the Raf-1 knock-down on proliferation 
48h after electroporation with 2 different Raf-1-siRNAs (Raf-1-1 and Raf-1-2) and lowGC-
siRNA as a control, the cells were seeded at the 3 different indicated concentrations 
(1x106 cells/ml, 2x106 cells/ml, 4x106 cells/ml) and the proliferation rate was analysed by 
Casy-counts at 3 different timepoints: 72h, 96h and 120h after electroporation.  
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3.3.2 Effects of the Raf-1 knock-down on the Casy profiles  
 
The cell suspensions were analysed daily by the CASY-cell analyser starting from 
24 to 120 hours after electroporation. We could detect a difference between the 
CASY-profiles (cell size distribution) of the cells with reduced Raf-1 levels and the 
control cells. Figure 24 shows the CASY-profiles of the different cells at the 
indicated time points. 24h after electroporation, cells electroporated with the Raf-1-
siRNAs did not show remarkable differences compared to the control cells. 
Importantly, 120 hours after electroporation a clear shift towards smaller cell size 
could be observed and also a defined peak of differentiated cells could be noticed 
in the profiles of Raf-1 deficient cells. The decrease in size and is one hallmark of 
differentiation (see figure 24).  
  
 
24h after electroporation: 
 
 
low GC:          Raf-1-2:    Raf-1-1: 
 
 
 
 
 
 
 
 
 
 
120h after electroporation: 
 
 
low GC:            Raf-1-2:     Raf-1-1: 
 
 
 
 
 
 
 
 
 
 
  
Figure 24: Casy Profiles 24h and 120h after electroporation 
After electroporation with 2 different Raf-1-siRNAs (Raf-1-1 and Raf-1-2) and lowGC-siRNA 
as a control, cell numbers were analysed daily (24h to 120h after the electroporation) by 
the CASY-cell analyser. CASY-profiles show cell-size distribution. 
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3.3.3 Effects of the Raf-1 knock-down on the cell morphology 
 
The cell morphology of the different cells was analysed via cytocentrifugation onto 
glass slides and subsequent staining with benzidine and hematological dyes 
(cytospins). Such cytospins were perfomed and analysed with each approach in 
the accordant cell concentration.  
We found that the cytospins of Raf-1 deficient cells showed more differentiated 
cells relative to the control cells; this effect was noticed at low cell densities (1x106 
cells/mL) (see figure 25 (A)). Against the effects detected on the proliferation rate, 
the cytospins of Raf-1 deficient cells seeded at higher concentrations showed no 
significant difference in differentiation compared to the control cells (low-GC). The 
shown experiment was performed with EPC culture (isolated from cord blood), 
with an innately high spontaneous differentiation. Thus, at higher concentrations 
(2x106 cells/mL and 4x106 cells/mL) the levels of differentiating cells were also 
increased in the control cells (see figure 25 (B) and (C)).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Cell concentration:  
  
         1x106 cells/mL 
lowGC: x40 Raf-1-1: x40 
Raf-1-2: x40 
A) 
Results 
81 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Raf-1 deficient cells show higher spontaneous differentiation 
48h after electroporation with 2 different Raf-1-siRNAs (Raf-1-1 and Raf-1-2) and 
lowGC-siRNA as a control, the cells were seeded at 3 different concentrations (A) 
1x106 cells/ml, (B) 2x106 cells/ml, (C) 4x106 cells/ml). 24h to 120h after the 
electroporation cell aliquotes were cyto-centrifuged onto glass slides and stained. Here 
are shown the cytospins of the time-point 120h after the electroproation.  
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Nevertheless, we could show that the reduction of Raf-1 resulted in an increase of 
spontaneously differentiated cells when seeded at a concentration 1x106cells/mL. 
The cells with lower Raf-1 protein levels show a decrease in size and an increased 
hemoglobin accumulation, two parameters which are typical signs for terminal 
differention (see figure 25 (A)). 
 
 
3.3.4 Effects of Raf-1 knock-down on pERK- and Caspase-3 levels 
 
In the mouse erythroid cells Raf-1 has been demonstrated to stimulate ERK 
activation and thereby to inhibit Caspase activation, which is involved in the 
differentiation processes (Rubiolo et al., 2006). 
 
To analyse whether Raf-1 has a similar function in human cells, we analysed the 
phosphorylation of ERK- and the cleavage of Procaspase-3 on protein level in the 
electroporated cell. Electroporation was performed in 2 different EPC- cultures 
isolated from 2 different cord blood donors (LT11 and CB14). Cells were 
electroprated with 2 different Raf-1 siRNAs (Raf-1-1- and Raf-1-2- siRNA); and the 
non coding lowGC-siRNA and one approach electroporated without siRNA served 
as negative controls. The knock-down efficiency and the pERK- and Procaspase-
3- levels were analysed by Westernblotting 72h or 96h after electroporation (figure 
26).  
 
As demonstrated on the left panel of figure 26, when Raf-1 knock-down was 
performed in cord blood LT11, 72h after electroporation, the pERK levels were 
slightly reduced (in the approach electroporated with Raf-1-2-siRNA), whereas the 
Procaspase-3 levels remained unchanged. Furthermore, in the approach 
electroporated with the Raf-1-1 siRNA, where the knock-down was even stronger 
compared to the Raf-1-2 oligo, the pERK levels were not reduced, but Caspase-3 
(which is correlating with reduced Procaspase-3) was slightly activated.  
On the other hand in the Raf-1 knock-down performed in cord blood CB14 (see 
right panel of figure 26), the pERK-levels were slightly reduced compared to the 
lowGC-control and the Caspase-3 was activated (shown is the reduction of 
Procaspase-3), especially in the approach electroporated with Raf-1-2 –siRNA.  
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Effects of Raf-1 knock-down on pERK- and Caspase-3 levels 
 
Raf-1 knock-down in LT11 (72h):         Raf-1 knock-down in CB14 (96h): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Thus, we could detect in the human system similar effects as reported in the 
mouse system. Unfortunately, when the Raf-1 knock-down was performed in other 
EPC cultures from a different donor, the effects could not be reproduced: there 
were no effects on the phosphorylation of ERK or on the cleavage of Procaspase-
3.  
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Figure 26: Effect of Raf-1 knock-down on pERK and Caspase-3 levels 
Electroporation was performed in 2 different EPC cultures from 2 different cord blood 
donors (LT11 and CB14). Cells were electroporated with 2 different Raf-1 siRNAs (Raf-1-
1- and Raf-1-2- siRNA); the non coding lowGC-siRNA and one approach electroporated 
without siRNA (no oligo) served as negative controls. The knock-down efficiency and the 
effects on the pERK- and Procaspase-3- levels were analysed by Westernblotting 72h or  
96h after electroporation. 
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3.4 Tis11d: Zinc Finger Protein 36 like 2  
 
In a microarray screen Tis11d has been identified as a glucocorticoid target gene. 
Tis11d is a zinc-finger-like protein and member of the Tis11-family. The Tis11-
family consists of four mammalian members: TTP, Tis11b, Tis11d and Zfp36L3 
(expressed only in rodents) (Baou et al., 2009). 
We analysed the expression levels of all of the three Tis11-like proteins in human 
EPCs on mRNA-level by Q-PCR and as shown in figure 27, we found that Tis11d 
was the highest expressed zinc-finger-like protein in erythroid cells. While the 
Tis11b-expression was extremly low, TTP showed intermediate expression levels.  
 
  
 
 
 
 
 
 
 
 
 
 
 
To study the function of Tis11d in hEPCs we performed a Tis11d knock-down with 
three different Tis11d-siRNAs (Tis11d-1, -2, -3).  
The two non-coding low GC- and high-GC-siRNAs and one approach without 
siRNA (no oligo) served as negative controls. 72h after the electroporation we 
showed an over 80% decrease of the Gapdh protein level when using Gapdh-
siRNA as a positive control (figure 28). With the siRNA Tis11d-2, the Tis11d 
protein-levels could be reduced by over 70% on protein-level 72 hours after 
electroporation as shown in figure 28 (A). Importantly also the mRNA-levels were 
reduced by over 60% after 72h in the samples treated with the siRNA Tis11d-2, as 
demonstrated in figure 28 (B). 
 
Figure 27: Expression levels 
of Tis11-like proteins in 
human EPCs 
 
The levels of Tis11d, TTP and 
Tis11b were analysed by Q-
PCR in hEPCs (d14).  
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A) Knock-down on protein-level (72h)   B) Knock-down on mRNA-level (72h) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.1 Effect of the Tis11d knock-down on cell morphology 
 
In the cell samples in which Tis11d- levels were reduced, we noticed an increase 
of apoptotic cells in cytospin preparations 96h after the electroporation. As 
mentioned above, when cells undergo apoptosis specific morphological changes 
within the cell can be observed: cytoplasm condensation, nucleus shrinkage, 
nuclear chromatin condensation, breakage of the cells into membrane-bound 
apoptotic bodies, which are containing a variety of cytoplasmic organelles and 
nuclear fragments. As shown in figure 29, in the cytospins of the Tis11d-deficient 
cells exactly these morphological changes could be observed: When Tis11d was 
knocked down, more cells with condensed and fragmented nuclei and apoptotic 
body formations could be detected, those cells are pointed out in the cytospins 
shown in the figures below by black arrows. The dead and apoptotic cells were 
counted and are shown as % of total cells (figure 29 (B)). In the approaches where 
Tis11d has been knocked down, an increase of approximatley 16% of dead and 
apoptotic cells relative to the low-GC control was determined.  
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Figure 28: Tis11d knock-down 72h after electroporation 
2x106 cells per approach were electroporated with 3 different Tis11d- siRNAs (Tis11d-1, -2, 
-3). The Gapdh-siRNA was used as a positive control; the non-coding low GC-, and high 
GC-siRNAs and one approach electroporated without siRNA (no oligo) served as negative 
controls. 72h after electroporation the knock-down was analysed on protein-level by 
Westernblot-analysis (A) and on mRNA-level by Q-PCR (B).  
 
 
Knock-down was analyzed by Westernblotting (A) and Q-PCR (B).   
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A) 
 
 
 
 
 
 
 
 
 
 
B) 
 
   living cells: 
 
 
 apoptotic cells: 
 
 
 
 
 
 
 
 
The experiment was repeated with another batch of EPCs from a different donor, 
and we observed a reproducible increase in apoptotic cells only in the approach, 
where Tis11d was effectively downregulated. Electroporation was performed with 
3 different Tis11d- siRNAs (Tis11d-1, -2, -3). The non-coding low-GC-siRNA, the 
apoptosis-inducing siRNA and one approach electroporated without siRNA (no 
oligo) served as negative controls. Figure 30 (A) shows the cytospins of the 
different approaches, in which the black arrows point out the cells with the 
condensed and fragmented nuclei. Dead and apoptotic cells were counted and 
compared to the total cell number and shown as a % of cells in figure 30 (B). 
Figure 29: Increase of apoptotic cells 96h after Tis11d-knock-down 
(A) 96h after electroporation cell aliquots were cyto-centrifuged onto glass-slides and 
stained as described (microscope: x40). Black arrows point out the cells with condensed 
and fragmented nuclei and apoptotic body formations during apoptosis. (B) Dead and living 
cells were counted and are shown as % of total cells. 
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Figure 30: Increase of apoptotic cells 72h after Tis11d-knock-down 
(A) 72h after electroporation with 3 different Tis11d-siRNAs and lowGC-siRNA and 
apoptosis-inducing siRNA as controls, cell aliquots were cyto-centrifuged onto glass-slides 
and stained (microscope: x40). The knock-down was achieved with the Tis11d-2 siRNA. In 
this approach were more dead and apoptotic cells were detectable, pointed out by black 
arrows. (B) Dead and living cells were counted and are shown as % of total cells.  
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The most efficient downregulation of Tis11d was achieved with the Tis11d-2-
siRNA and as shown in figure 30 exactly in this approach approximately 24% 
apoptotic cells could be determined, whereas in the low GC control sample only 12 
% of the cells were apoptotic. The cells electroporated with the low GC- control or 
with the ineffective Tis11d-siRNAs, which didn’t reduce the expression of Tis11d, 
showed mainly big cells with a large nucleus and a high amount of cytoplasm, 
whereas the cells with reduced Tis11d protein levels showed an increased amount 
of dead cells with small, dark and fragmented nuclei and a condensed cytoplasm 
(evaluated in figure 30 (A)). 
 
 
3.4.2 Effect of the Tis11d knock-down on cell volume and cell size 
 
When cells undergo apoptosis a condensation of the cytoplasm occurs, before the 
nucleus becomes defragmented. To analyse this morphological changes, an 
additional electroporation was performed and the mean cell volume and the mean 
cell diameter of the different approaches were analysed 24h to 96h after 
electroporation by the CASY Cell Analyser. The Casy-measurements give 
information about the cell count and the cell size.  
 
The electroporation was performed with the Tis11d-2 siRNA. Gapdh-siRNA and an 
apoptosis-inducing siRNA were used as positive controls, and the non-coding low 
GC-siRNA served as a negative control.  
  
We observed that cells with lower Tis11d levels show a decrease in the mean cell 
volume and in the mean cell diameter after the electroporation, as shown in figure 
31. The decrease of cell size is as high as in the approach electroproated with the 
apoptosis-inducing-siRNA, where over 80% of the cells died 96h after the 
electroporation. 
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Effect of Tis11d knock-down on mean cell volume and mean cell diameter: 
 
 
A) Decrease in mean cell volume 24h-96h after the electroporation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B) Decrease in mean cell diameter 24h-96h after the electroporation 
 
Figure 31: Decrease of mean volume (fl) and mean diameter (µm) 
24h to 96h after the electroporation with Tis11d-2-, lowGC-, GAPDH-, and apoptosis 
inducing –siRNA, the cells were counted daily by the CASY-cell analyzer. The Casy-
profile gives you the cell count and as well the cell size (the mean cell volume (A) and (B) 
mean cell diameter). 
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3.4.3 Effect of the Tis11d knock-down on cell viability 
 
By comparing the cells treated with the positive control for apoptosis with the 
effects obtained with the reduction of Tis11d, we could prove that downregulation 
of Tis11d induces apoptosis.  
 
To verify the apoptosis-inducing function, we performed further Tis11d knock-
downs with three different hEPC- cultures and analysed the cell viability by FACS 
analysis. Thus, mononuclear cells were isolated from three different cord bloods 
(CB14, LT8 and LT9) and cultivation of EPC was performed as described in 
Materials and Methods until day 14, when the electroporation was performed with 
two Tis11d- siRNAs (Tis11d-1 and Tis11d-2). The non-coding low GC-siRNA 
served as a negative- and the Gapdh-siRNA as a positive- control. The 
downregulation on protein-level was analysed 96h after the electroporation by 
Western-Blotting.  
 
The knock-down efficiency of Tis11d and Gapdh on protein-level varied depending 
on the used cord blood sample. As shown on the left panel of figure 32 the highest 
Tis11d knock-down could be achieved in EPCs isolated from the cord blood CB14, 
in which 96h after the electroporation the Tis11d levels could be reduced by over 
80%, whereas in EPCs isolated from the cord blood LT8 and LT9 the knock-down 
efficiency was lower. 96h after the electroporation the cell viability of each 
approach was measured by an Annexin-V-staining by FACS-analysis, and the 
results are shown in the right panel of Figure 32.  
 
As shown in figure 32, we found that a reduction of Tis11d-protein levels resulted 
in an increase of dead and apoptotic cells, measured as Annexin-V-positive cells 
in all of the three different hEPC cultures. 
In the approaches where Tis11d has been down-regulated efficiently (depending 
on the cord blood, either with the Tis11d-1- or Tis11d-2- siRNA), nearly a two- fold 
higher amount of dead and apoptotic cells was measured. 
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A) Tis11d knock-down in CB14 (96h) 
 
 
 
 
 
 
 
 
 
B) Tis11d knock-down in LT8 (96h) 
 
 
 
 
 
 
 
 
 
 
C) Tis11d knock-down in LT9 (96h) 
 
 
 
 
 
 
 
 
 
 
  
Figure 32: Tis11d knock-down induces apoptosis 
Tis11d knock-down was performed in 3 different EPC cultures isolated from 3 different cord blood 
samples (A) CB14, (B) LT8, (C) LT9. The non-coding lowGC-siRNA and Gapdh-siRNA were used 
as controls. 96h after the electroporation the knock-down was analysed by Western Blotting, as 
shown on the left panel of the figure. In each approach the cell viability was measured by an 
Annexin-V-staining by FACS analysis and is shown on the right panel of the figure. 
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In figure 33 the cell viability data of those 3 different experiments are taken 
together and illustrated with the according standard deviation. In summary the 
downregulation of Tis11d led to an 1,7 fold increase of Annexin-V-positive cells, 
when compared to the cells transduced with lowGC-siRNA (relative to lowGC=1).  
A performed student's t-test showed that the differences are statistically significant 
(the p-value was 0,027).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.4 Effect of the Tis11d knock-down on Caspase-3 levels 
 
When cells undergo apoptosis several pathways can be involved. To analyse if the 
apoptotic effect, seen after the Tis11d knock-down (shown on the left panel of 
figure 32), is mediated either by intrinsic or extrinsic pathways, the levels of 
Procaspase-3, -8 and BAX were analysed by Westernblotting. (Results are shown 
in figure 34).  
 
When Tis11d levels are reduced, we saw that Caspase-3 is activated, while the 
pERK-levels are reduced. We analysed the levels of the Procaspase-3 (figure 34), 
whose downregulation correleates with Caspase-3 activation. 
 
Figure 33: Tis11d knock-
down induces apoptosis 
Tis11d knock-down led to 
an increase of Annexin-V-
positive cells (relative to 
lowGC=1). Data of three 
independent experiments, 
performed with 3 different 
EPC-cultures, isolated from 
3 different cord blood 
samples. 
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Effect of the Tis11d knock-down on Caspase-3 levels 
 
A) First Tis11d knock-down in CB14 (96h)    B) Tis11d knock-down in LT8 (96h) 
 
 
 
 
 
 
 
 
 
 
 
 
 
C) Second Tis11d knock-down in CB14 (72h) 
 
         
 
 
 
 
 
 
 
 
 
 
 
Surprisingly the BAX-levels were also down-regulated after reduction of Tis11d 
(figure 34 A). The Westernblot results concerning the caspase-8 are not conclusiv, 
since the used antibody gave too high background levels (data not shown).  
Figure 34: Downstream effects of 
the Tis11d-knock-down 
Tis11d knock-down was performed in  
3 independent experiments, with two 
different hEPC-cultures (isolated from 
two different cord blood samples CB14 
and LT8). 96h and 72h after the 
electroporation the knock-down 
efficiency of Tis11d was analysed by 
Westernblotting. Here are shown the 
downstream effects of the Tis11d 
downregulation on the pERK-, 
Procaspase-3- and Bax-levels.  
Downregulation of Procaspase-3, 
correlates with activation of Caspase-3.  
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3.4.5 Effect of the Tis11d knock-down on TNFα-levels 
 
Members of the Tis11-protein-family have been reported to be able to bind to 
ARE- containing mRNAs and subsequently induce their degradation (Lai et al., 
1999). Tristetraprolin (TTP) is the most studied member of this family and it has 
been shown in several publications that TTP can bind directly to the AU-rich 
element in the TNF-α mRNA and thereby induce its degradation (Carballo et al., 
1998; Lai et al., 1999; Lai et al., 2000; Stumpo et al., 2009).  
To analyse whether downregulation of Tis11d affects expression of TNF-α, we 
measured the mRNA-level of TNF-α by real-time PCR (Q-PCR) in cells with 
reduced Tis11d levels (see figure 35).  
 
 (A) normalised to the housekeeper                 (B) not normalised to the housekeeper 
 
 
      
 
(C) Tis11d knock-down (96h) 
 
 
 
 
 
 
 
Figure 35: TNF-α levels after Tis11d-knock-
down 
Electroporation was performed with 2 different 
Tis11d-siRNAs. Gapdh-siRNA was used as a 
positive control. 96h after the electroproatin the 
Tis11d knock-down was analysed by 
Westernblotting (C). The TNF-α mRNA-levels in 
the approaches electroproated with the 2 
different Tis11d-siRNAs, and the Gapdh-siRNA 
were analysed by Q-PCR (A) and (B).  
(A) On the left panel of the figure are shown the 
TNF-alpha mRNA-levels when normalised to the 
housekeeper CSNK1d and on the right panel of 
the figure are shown (B) the Q-PCR results of 
the TNF-alpha levels evaluated according the 
dCT-values. 
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When the Q-PCR-data were evaluated relative to the housekeeper CSNK1d 
(Casein kinase I isoform delta) (see figure 35 (A)), we could not detect a difference 
of TNF-α mRNA expression after the Tis11d knock-down (figure 35 (C)). 
But if the TNF- α levels were determined only according the dCT-values we could 
demonstrate a nearly 3-fold increase of TNF-α mRNA in the absence of Tis11d, as 
shown on the right panel of Figure 35 (figure 35 (B and C)). 
 
As secreted TNF-α protein could also be responsible for the increased apoptosis; 
we tried to measure the amount of TNF- α in the supernatant of the erythroid cells. 
Therefore the supernatant of the different approaches of the Tis11d knock-down 
was collected and the TNF- α levels were analysed by ELISA (Enzyme- linked 
immunosorbent assay).  
Unfortunately we could not detect TNF-α in the analysed samples. Probably the 
TNF-α levels of the tested samples were below the limit of detection of the assay, 
which was in the range of 10 pmol TNF-α (data not shown). Although we could 
show that the mRNA for TNF-α is present in these cells, we couldn’t measure 
TNF-α in our samples. Additionally, we can not exclude that soluble TNF-α is not 
produced in hEPCs. 
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3.5 Fkbp51: FK506-binding protein 51 
 
To study the function of FKBP51 in primary hEPCs we performed a knock-down 
with three different Fkbp51-siRNAs (Fkbp51-1, Fkbp51-2, and Fkbp51-3). The 
non-coding low GC-, med- and high GC-siRNAs were used as negative controls. 
The knock-down efficiency was analysed 72h after the electroporation by 
Westernblotting, as shown in figure 36 (A). With all three siRNAs the expression of 
FKBP51 could be reduced by over 90% on protein-level (data of the FKBP51 
knock-down induced by the Fkbp51-1-siRNA are not shown). Importantly also the 
mRNA-levels were reduced by over 60% to 75% with all three siRNAs 72h after 
electroporation, as shown in Figure 36 B). 
 
 
(A)  Knock-down on protein-level (72h)       (B) Knock-down on mRNA-level (72h) 
 
 
 
 
   
 
 
 
 
 
 
 
 
3.5.1 Effect of FKBP51 knock-down on cell morphology 
 
When FKBP51- levels were reduced we again observed an increase of apoptotic 
cells. This effect was further analysed using cytospins. In the appraoches where 
FKBP51 has been knocked down, a two fold increase of apoptotic cells relative to 
the low GC control could be detected, as shown in figure 37. The cytospins of the 
cells with reduced FKBP51-levels showed more cells with a condensed nucleus 
and cytoplasm. The apoptotic cells are indicated by black arrows.  
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siRNA Figure 36: FKBP51 knock-down 72h after electroporation 
2x106 cells per approach were electroporated with 3 different FKBP51- siRNAs (FKBP51-1, 
-2, -3). The non-coding low GC-, and high GC- siRNAs were used as negative controls. 
72h after electroporation the knock-down was analysed on protein-level by Westernblot-
analysis (A) and on mRNA-level by Q-PCR (B).  
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   living cells: 
 
 
 apoptotic cells: 
 
 
 
 
 
 
 
 
 
 
The experiment was repeated with another batch of EPCs from a different cord 
blood sample (LT11), and we observed a reproducible increase in apoptotic cells 
in both approaches, where FKBP51 was effectively knocked down (data not 
shown).
Low GC-siRNA: x40 Fkbp51-siRNA: x40 
Figure 37: Increase of apoptotic cells 96h after FKBP51-knock-down 
(A) 96h after electroporation cell aliquots were cyto-centrifuged onto glass-slides and 
stained (microscope: x40. Black arrows point out the cells with condensed and 
fragmented nuclei and apoptotic body formations after downregulation of the FKBP51-
levels. (B) Dead and living cells were counted and are here shown as a % of cells. 
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Electroporation was performed with 2 different FKBP51- siRNAs (FKBP51-1, -2). 
The non-coding low GC-siRNA and one approach electroporated without siRNA 
(no oligo) served as negative controls. Knock-down efficiency was analysed by 
Westernblotting 72h after the electroporation and the results are shown in figure 
38. With both used FKBP51-siRNAs we could significantly reduce the protein 
levels of FKBP51.  
 
 
FKBP51 knock-down in LT11 (72h):  
 
 
 
 
   
 
 
 
 
 
 
Figure 39 shows the morphological analysis of the different approaches. The cells 
electroporated with the low GC- control showed mainly big cells with a large 
nucleus and a high amount of cytoplasm, whereas the cells with reduced FKBP51 
protein showed an increased amount of cells with small, dark and fragmented 
nuclei and a condensed cytoplasm, all hallmarks of apoptosis. The dead cells are 
pointed out by black arrows (figure 39 (A)). 
 
Dead and apoptotic cells were counted and are shown as a % of cells in figure 39 
(B). In both approaches, where FKBP51 levels were reduced, approximately 24% 
of apoptotic cells could be determined, whereas in the low GC control sample only 
12% of the cells were apoptotic. Thus, reduced FKBP51 leads to a two-fold 
increase of apoptosis in erythroid cells.  
 
Figure 38:  FKBP51- knock-down in 
LT11 
FKBP51 knock-down was performed in 
EPCs of a different cord blood sample 
(LT11) with two different FKBP51-
siRNAs (FKBP51-1 and FKBP51-2), the 
non-coding low GC-siRNA was used as 
a control. Knock-down efficiency was 
analysed by Westernblotting 72h after 
the electroporation. 
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 no-siRNA: 40x    
lowGC-siRNA: 40x    
Figure 39: Increase of apoptotic cells in FKBP51 deficient cells 
72h after electroporation with 2 different Fkbp51-siRNAs, cell aliquots were cyto-
centrifuged onto glass-slides and stained (microscope: x40). LowGC-siRNA and one 
approach electroporated without siRNA served as negative controls. (A) In the cytospins 
of FKBP51-deficient cells more dead and apoptotic cells were detectable. Dead cells are 
pointed out by black arrows. (B) Dead and living cells were counted and are shown as % 
of total cells.  
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3.5.2 Effect of FKBP51 knock-down on cell volume and cell size 
 
The mean cell volume and the mean cell diameter) of the cells were analysed 24h 
to 96h after the electroporation of the different approaches by the CASY-cell 
counter. We found that the cells with reduced FKBP51 showed a decrease in the 
mean volume and in the mean diameter at the analysed time points shown in 
figure 40 (A) and (B). Condensation of nuclei and cytoplasm during apoptosis is 
leading to reduced cell volume (measured by mean volume and diameter; see 
figure 40). Thus we found again that the reduction of the FKBP51 protein leads to 
induced apoptosis in hEPCs. 
 
 
A) Decrease in mean cell volume 24h-96h after the electroporation 
 
 
 
 
 
 
 
 
 
 
B) Decrease in mean cell diameter 24h-96h after the electroporation 
 
 
 
Figure 40:  Decrease of mean volume (fl) and mean diameter (µm) 
24h to 96h after the electroporation with FKBP51-1-siRNA (lowGC-siRNA, Gapdh-siRNA  
and apoptosis-inducing siRNA were used as controls), the different approaches were 
counted and the mean volume (A) and the mean diameter (B) were analysed by the CASY-
cell counter. The casy profiles show cell count and cell size. 
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Effect of FKBP51- knock-down on cell viability 
 
(A) Knock-down in CB14 (96h)   
 
 
 
 
 
 
 
 
(B) Knock-down in LT8 (96h)  
 
 
 
 
 
 
 
 
 
(C) Knock-down in LT11 (72h) 
                                                         
 
 
Figure 41: FKBP51 knock-down induces apoptosis  
FKBP51 knock-down was performed in 3 different EPC cultures isolated from 3 different cord 
blood samples ((A) CB14, (B) LT8, (C) LT11). The non-coding lowGC-siRNA was used as a 
control. 96h or  72h after the electroporation the knock-down was analysed by Western Blotting, as 
shown on the left panel of the figure. Cell viability was measured by FACS analysis (Annexin-V-
staining) and is shown on the right panel of the figure. 
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3.5.3 Effect of FKBP51 knock-down on cell viability 
 
To analyse whether the reduction of FKBP51 is inducing apoptosis, further 
FKBP51 knock-downs were performed with three different hEPC- cultures isolated 
from 3 different cord blood samples (CB14, LT8, LT11) and cell viability was 
analysed by flow cytometry.  
Electroporation was performed with two FKBP51- siRNAs (FKBP51-1 and 
FKBP51-2). The non-coding lowGC-siRNA and one approach electroporated 
without siRNA (no oligo) served as negative- controls. The downregulation on 
protein-level was analysed 96h and 72h after the electroporation by Western-
Blotting (shown in left panel of figure 41). The knock-down efficiency of FKBP51 
and Gapdh on protein-level varied depending on the cord blood sample and the 
analysed time-point (72h or 96h). We saw that a reduction of FKBP51-expression 
also resulted in an increase of AnnexinV-positive cells (right panel of figure 41).  In 
the approach with the maximal FKBP51 reduction, an increase of apoptotic and 
death cells of up to 1,6 (relative to lowGC=1) could be measured (see right panel 
of figure 41).  
In figure 42 the cell viability data of those 3 different experiments were taken 
together and are illustrated with the according standard deviation. In summary the 
downregulation of FKBP51 led to an 1,55 fold increase of Annexin-V-positive cells, 
when compared to the cells transduced with lowGC-RNA (relative to lowGC=1).  
A performed student's t-test showed that the differences are statistically significant 
(p-value was 0,004). 
 
 
 
 
 
 
.  
 
 
 
Figure 42: FKBP51 
knock-down induces 
apoptosis 
 
FKBP51 knock-down led 
to an 1,55 fold increase of 
Annexin-V-positive cells 
(relative to lowGC=1). 
Data of three independent 
experiments, performed 
with three different EPC-
cultures, isolated from 
three different cord blood 
samples. 
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3.5.4 Effect of FKBP51 knock-down on NF-kB levels 
 
FKBP51 is a multifunctional protein and its expression is induced by 
glucocorticoids. It has been reported that FKBP51 might be implicated in the 
regulation of NF-kB activation and that FKBP51 links the glucocorticoid signaling 
to the NF-kB signaling pathway (Komura et al., 2005; Park et al., 2007; Romano et 
al.). When FKBP51 was overexpressed in megakaryocytes of human idiopathic 
myelofibrosis (IMF) patients, Komura et al. could demonstrate that this 
overexpression led to resistance to apoptosis. And at the same time 
overexpression of FKBP51 in this hematopoietic cell line, induced a sustained NF-
kB activation. But this relationship between FKBP51 overexpression and a 
constitutive NF-kB activation in megakaryocytes needs further approval (Komura 
et al., 2005).  
 
Therefore, also in our studies we analysed the effects of the FKBP51 
downregulation on the NF-kB levels in primary human erythroid progenitor cells.  
FKBP51 knock-down was performed in three independent experiments with 
different FKBP51 siRNAs (FKBP51-1,-2,-3) in 2 various EPC cultures (LT11 and 
CB14) isolated from 2 different cord blood samples. The non-coding lowGC-, med-
GC-siRNAs and one approach not electroporated at all (no elpo) served as 
negative controls. The knock-down efficiency of FKBP51 varied depending on the 
EPC culture and on the analysed time-point. 72h and 96h after electroporation the 
downstream effects of the FKBP51 downregulation on the phosphorylated and 
unphosphorylated IKKα/β-, IKBα-, NF-kB- and the Procaspase-3- levels were 
analysed by Westernblotting.   
 
As shown in Figure 43, we could demonstrate that in hEPCs the phosphorylation 
of NF-kB and as well the unphosphorylated NF-kB-levels were reduced after 
FKBP51 downregulation. Additional to the NF-kB- levels, we found that the pIKKα- 
and pIKBα- levels were downregulated, whereas Caspase-3 levels seemed not be 
affected (see Figure 43). These effects could be reproduced several times (data 
not shown).  
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Downstream effects of FKBP51 knock-down 
 
 
(A) FKBP51 knock-down in LT11 (72h)                  (B) FKBP51 knock-down in CB14 (72h)           
 
 
 
 
  
  
 
 
  
 
 
 
 
 
(C) FKBP51 knock-down in CB14 (96h)          
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 43: Fkbp51 knock-down led 
to downregulation of pNFkB levels 
FKBP51 knock-down was performed in 
three independent experiments with 
different FKBP51 siRNAs (FKBP51-1,-2, 
-3) in 2 EPC cultures ((A) LT11 and 
CB14 (B) and (C)) isolated from 2 
different cord blood samples. The non-
coding lowGC- and med-GC-siRNA and 
one approach not electroporated at all 
(no elpo) served as negative controls. 
The downstream effects of the FKBP51 
downregulation on the phosphorylated 
and unphosphorylated IKKα/β-, NFkB-, 
the IKBα-, and the Procaspase-3- levels 
were analysed by Westernblotting 72h or 
96h after electroporation.  
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 3.6 Tis11d knock-down leads to FKBP51 downregulation 
 
After we performed a Tis11d knock-down and FKBP51 knock-down together in 
one experiment, we could show that reduction of the Tis11d levels, led also to a 
downregulation of FKBP51. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In this experiment the non-coding medGC-siRNA was used as a control and the 
knock-down efficiency on mRNA level was analysed 96h after the electroporation 
by Q-PCR shown in figure 44. We could show that Tis11d knock-down led also to 
a dramatically decrease of FKBP51 on mRNA level and on protein level (data not 
shown). FKBP51 levels were reduced up to 85% in the approach, where Tis11d 
has been knocked down. A possible interaction between those two GR-target 
genes is estimated. 
 
Figure 44: FKBP51 mRNA levels after Tis11d and FKBP51 electroporation 
Electroporation was performed with Tis11d- and FKBP51-siRNAs, medGC-siRNA was 
used as a control. The FKBP51 mRNA levels were analysed by Q-PCR and shown 
in % relative o medGC-siRNA.  
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4. DISCUSSION 
 
 
4.1 Raf-1  
 
 
The family of Raf kinases consists of 3 different isoforms: A-Raf, B-Raf and Raf-1, 
which are expressed during the embryonic development. The 3 Raf isoformes are 
regulated differentially by upstream activators and show differences in their ability 
to activate MEK (Mikula et al., 2001). The best studied Raf isoform is Raf-1, which 
has been shown to be implicated in mechanisms regulating proliferation, 
differentiation and survival of mouse erythroblasts, by preventing apoptosis and 
and promoting proliferation.  
 
Mikula et al. reported that Raf-1 deficient mouse embryos are anaemic, have 
hypocellular livers and die at E12.5 due to hepatoblast failure. Raf-1 deficient fetal 
livers contained fewer erythroid progenitors than WT livers (Mikula et al., 2001). 
Additionally it has been shown that during differentiation of primary mouse 
erythroblasts Raf-1 protein is degraded and that overexpression of Raf-1 can 
delay terminal erythroyid differentiation by inhibiting activation of Caspases  
(Kolbus et al., 2002). Thus, the anaemic phenotype of the embryos lacking Raf-1 
could be linked to the premature differentiation of erythroblasts.  
 
Furthermore it has been reported that Raf-1-deficient mouse erythroblasts 
differentiated much faster than the wild-type erythroblasts. In the cytospins of Raf-
1 deficient cells immature, mature and hemoglobinized cells could be found, 
whereas the control cells consisted mainly of large and undifferentiated cells. 
When differentiation was initiated (by high EPO and insulin) in erythroblasts, cells  
lacking Raf-1, showed a dramatic increase of nucleated and enucleated 
erythrocytes with accelerated differentiation compared to WT cells (Kolbus et al., 
2002). 
 
Those in vivo and in vitro studies revealed that in the mouse system Raf-1 seems 
to be involved in the regulation of differentiation and proliferation of erythroid 
progenitor cells.  
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4.1.1 Raf-1 knock-down in hEPCs led to more spontaneous differentiation 
 
Little is known about the function of Raf-1 in human erythropoesis. Thus, in our 
study we analysed whether Raf-1 is also implicated in the differentiaton and 
proliferation process of human erythroid cells by using Raf-1 knock-down 
approaches in primary human erythroid progenitor cells.  
We could show that cells with reduced protein levels of Raf-1 proliferated slower 
when compared to control cells. This effect was better detectable, when the cells 
were cultivated at higher cell densities. When the cell morphology was analysed 
via cytospins, Raf-1 knock down cells showed more spontaneously differentiated 
cells. The CASY profiles of Raf-1 downregulated cell-cultures were shifted to the 
left, indicating a decrease in cell size which is characteristic for terminal erythroid 
differentiation. Unfortunately, in the experiments performed in the presented study, 
the difference between the control cells and the cells with low Raf-1 levels were 
not as prominent as in the mouse system. This could be due to the fact that the 
used control cells showed an increased spontaneous differentiation, which may 
superimpose the effect of Raf-1 downregulation.   
 
In erythroid cells Caspases are not only involved in apoptotic mechanisms, but 
they have been shown to play an important non-apototitc role in the differentiation 
mechanisms. Carlile et al. for example demonstrated that reduction of Caspase 
activity during early human erythropoiesis resulted in a block of erythroid 
maturation. Without Caspase activation human erythroblasts did not develop 
beyond the pronormoblast stage (Carlile et al., 2009). Caspases are activated by 
Fas, which is a member of the tumor necrosis factor family of receptors. As Raf-1 
downregulation has been shown to correlate with up-regulation of Fas in the 
erythroid progenitors, it has been concluded that Raf-1 might therefore be involved 
indirectly in Fas activation (Rubiolo et al., 2006). Furthermore Raf-1 has also been 
shown to act as a MEK/ERK activator. 
 
Figure 45 is showing a scheme of the current hypothesis of the function of Raf-1 in 
mouse erythroblasts reported by Rubiolo et al.  According to this model in the 
mouse system ERK and Raf-1 are involved in a positive feedback loop.  
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Working model in the mouse system: 
 
When Raf-1 is present:  → caspase dependend differentiation is inhibited 
 
     
 
       
 
 
 
 
 
 
 
 
 
 
 
When Raf-1 is absent:  → caspase dependend differentiation is activated 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 45: Raf-1 stimulates proliferation and inhibits differentiation in mouse 
erythroid cells 
Glucocorticoids maintain the Raf-1 expression, which in order stimulates ERK acivation 
and thereby inhibits FAS. In this way Caspases activation is inhibited and EPCs 
undergo renewal. When the renewal stimulus is absent, Raf-1 is degraded, and ERK 
can not be activated. Thus Fas is present and induces Caspase activation and thereby 
induces differentiation (Rubiolo et al., 2006). 
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Raf-1 is required for ERK activation and activated ERK on the other hand 
maintains Raf-1 expression. Activated ERK inhibits FAS and thereby also the 
Caspase activation, whereby Caspase-mediated differentiation is repressed. This 
suggests, that in prescence of Raf-1, erythroblasts are maintained in an immature 
state (renewal). When Raf-1 is knocked down, the renewal stimulus is absent, as 
ERK can’t be activated and therefore Fas is present and induces Caspase 
activation and thereby differentiation. 
 
Also in our studies the downstream effects of the Raf-1 knock-down in hEPCs 
were analysed in the human system. According to the findings in the mouse 
system, in absence of Raf-1 we expected a downregulation of the pERK levels 
and an activation of the Caspase-3 levels. Caspase activation would explain the 
slight increase of spontaneous differentiation in our experiments. 
But again the effects were not as prominent as in the mouse system, the Caspase-
3 activation was very low and we didn’t notice remarkable effects on the 
phosphorylatian of ERK (pERK). Then there was the discrepancy that Caspase 
activation and pERK downregulation could not be detected in the same approach, 
either the Caspase-3 levels were affected or the pERK levels were downregulated. 
And even more remarkable was that in some experiments we couldn’t detect any 
effects on both, the Caspase-3 and the pERK-levels, although Raf-1 has been 
knocked down efficiently. Furthermore the effects of the knock-down on the 
spontaneous differentiation were not reproducible, as the effects couldn’t be 
reported in other experiments, where Raf-1 has been knocked down.  
Those findings therefore argue against the hypothesis that in human erythroid 
system Raf-1 has the same role in differentiation processes as reported in the 
mouse system. 
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4.2 TIS11d 
 
As mentioned above Tis11d is a zinc-finger-like protein and member of the Tis11-
family. The Tis11-family consists of four mammalian members:   
- TTP   (Tristetraprolin) 
- Tis11b (ZFP36l1 in the mouse system) 
- Tis11d  (ZFP36l2 in the mouse system) 
- Zfp36L3 
 
The fourth family member Zfp36L3 has been shown to be expressed only in 
rodents and in the mouse placenta, but has not yet been detected in human 
tissues so far. Characteristics of Tis11- like proteins are two tandem repeat zinc 
finger regions. The Tis11-like proteins have been shown to induce degradation of 
specific mRNAs (see figure 46). Through their zinc finger regions they are able to 
bind to the adenine-uridine (AU) rich elements (ARE) in the 3’-untranslated region 
of mRNAs and thereby they first promote deadenylation, then decapping and 
finally degradation of a variety of different mRNAs containing AU-rich elements 
(Baou et al., 2009; Wilusz et al., 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
A)Deadenylation     
 
C) 5’-3’ mRNA decay 
 
degraded mRNA 
 
 
B)Decapping 
 
C) 3’-5’ mRNA decay 
 
Figure 46: Members of the Tis11- family induce mRNA degradation 
Through their zinc finger region Tis11-like proteins bind to adenine-uridine (AU) rich 
elements of mRNAs and thereby promote deadenylation, decapping and finally degradation 
of mRNA (picture taken from: Baou et.al., 2009). 
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Interestingly, such AREs are also found at the 3’ end of each of the mRNAs of the 
Tis11- proteins, which suggests that they might regulate themselves by a negative 
feedback loop. The Tis11 family of proteins have an important role in 
posttranscriptional gene regulation and in the control of a variety of developmental 
and functional processes (Baou et al., 2009; Johnson et al., 2000).  
Little is known about the function of Tis11d in humans in general or specifically in 
erythropoiesis. In adult mouse tissues Tis11d is expressed at high levels in thymus, 
spleen, lung, uterus, ovary, small and large intestine, fat and bone marrow and 
lower levels in heart, kidney, eye, fetal liver, brain and skeletal muscle (Ino et al., 
1995).  
After we analysed the expression levels of all of the three Tis11-like proteins in 
human EPCs, we found that Tis11d was the highest expressed zinc-finger-like 
protein in erythroid cells. The high expression level of Tis11d in erythroid cells 
indicates that Tis11d is the most prominent member of the three Tis11 like family 
genes, and plays the most important role in these cells. 
 
Tis11b knock-out mice are embryonically lethal; they die in utero between day E8 
and E13, probably due to defective extraembryonic vasculogenesis (Bell et al., 
2006).  
Stumpo et al. demonstrated that in the mouse system Tis11d is involved in 
erythropoiesis and hematopoiesis. Zfp36l2 knock-out mice appeared normal until 
birth, but two weeks after birth they died of severe anemia. These knock-out mice 
showed significantly reduced levels of red and white blood cells, hemoglobin, 
hematocrit and platlets in peripheral blood analysis. Bone marrow analysis showed 
decreased myeloid and megakaryocyte cell populations. Loss of Zfp36l2 also led 
to a decreased level of hematopoietic progenitor cells (HPCs) and hematopoietic 
stem cells. Zfp36l2-/- fetal liver cells  were unable to reconstitute the hematopoietic 
systems in lethally irradiated mice, which suggests that Zfp36l2 might be required 
for self-renewal and maintenance of adult HSCs. By performing colony forming 
assays out of fetal liver cells from Zfp36l2 deficient cells, a significant lower 
number of erythroid BFU-E (burst formung units) and CFU-GM (granulocyte 
macrophage units) was observed (Stumpo et al., 2009). These studies indicate 
that Tis11d plays an important role in erythropoiesis and in definitive 
hematopoiesis during mouse development. 
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4.2.1 Downregulation of Tis11d in primary hEPCs induces apoptosis 
 
In our studies the downregulation of Tis11d in primary hEPCs resulted in an 
apoptotic phenotype. We could demonstrate that compared to the control cells, 
Tis11d-deficient cells showed an increase of approximatley 12% of dead 
/apoptotic cells in the cytospins 72h to 96h after the electroporation. Data of three 
independent experiments with three different hEPCs-cultures (isolated from three 
different cord blood samples) revealed that the downregulation of Tis11d led to an 
up to 1,7 fold increase of Annexin-V-positive cells, when compared to the cells 
transduced with lowGC-siRNA (relative to lowGC=1).  
 
Apoptosis can be mediated either by the instrinsic or extrinsic pathway (see 
chapter 1.6). As already mentioned the extrinsic pathway is initiated through the 
stimulation of the transmembrane death receptors, such as TNF-α-Receptor, 
wheareas the intrinsic pathway is initiated through the release of signal factors by 
mitochondria within the cell. In the extrinsic pathway Caspase-8 is directly inducing 
the cleavage of Procaspase-3 leading to the active form Caspase-3. And in the 
intrinsic pathway the activated Caspase-8 is first activating BID, which in turn 
activates BAK and BAX. Both pathways have at the end of the signalling cascade, 
an activated Caspase-3, which then induces apoptosis by cleaving several 
proteins in various cellular compartments.  
We could show that in every approach where Tis11d has been downregulated, the 
Procaspase-3 levels were decreased most probably by cleavage, leading to 
activation of Caspase-3.  This clearly demonstrated that the cells undergo 
apoptosis. We also could show that the BAX-levels were down-regulated in the 
cells with reduced Tis11d levels, which was quite surprisingly, as we expected 
either no effect on the BAX levels, if cells die through the extrinsic pathway, or an 
upregulation of BAX if apoptosis is induced through the intrinsic pathway. Thus it 
remains still unclear whether the erythroid cells undergo apoptosis through the 
intrinsic or the extrinsic pathway. 
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4.2.2 Targets of Tis11-like proteins 
 
Studies from TTP-, Tis11b- and Tis11d- knock-out mice revealed a lot of different 
mRNA- targets of Tristetraprolin in humans (see figure 47), but little is known 
about specific Tis11d- mRNA targets. The reported Tis11d- targets in humans are  
(Baou et al., 2009):   
 
→ TNF-α (Tumor Necrosis Factor alpha) 
→ GM-CSF (granulocyte-monocyte colony-stimulating factor)  
→ IL-3 (interleukin-3) 
 
The most studied member of the Tis11-family is Tristetraprolin (TTP). As shown 
in figure 47 the most prominent mRNA- target of TTP in humans is the tumor 
necrosis factor alpha (TNF-α).  
 
In 1998 Carballo et al. reported a possible interaction of TTP and TNF-α in studies 
of TTP-deficient mice. TTP-deficient mice appeared normal at birth, but after two 
weeks they were suffering of syndroms of infammatory arthritis, autoimmunity, and 
extramedullary hematopoiesis, which were typical syndroms of TNF-α- excess 
(Taylor et al., 1996). These findings suggested that TNF-α seemed to be target of 
Tristetraprolin and that TTP might induce degradation of TNF-α-mRNA. Abscence 
of TTP led to abnormal accumulation of TNF-α- mRNA and protein. It has also 
been demonstrated that macrophages isolated from TTP-/- fetal livers secreted 
five-times more TNF-α compared to the control cells (Carballo et al., 1998). 
Furthermore, the cellular levels of TNF-α-mRNA were two times higher compared 
to the wild-type macrophages. The half-life of the TNF-α mRNA in macrophages 
increased from 12 minutes (WT) up to 39 minutes in macrophages lacking TTP. 
Therefore they could show that TTP regulates the amount of TNF-α mRNA 
postranscriptionally and not by inhibiting gene expression. This TNF-α 
accumulation was responsible for the development of a systemic inflammatory 
syndrome characterized by arthritis, skin lesions, autoimmunity and myeloid 
hyperplasia (Carballo et al., 1998; Lai et al., 1999; Taylor et al., 1996). 
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Figure 47: Human Tis11 family members and their reported mRNA targets 
Tristetraprolin is the most studied member of this family, with the most known mRNA-
targets in humans. For Tis11d there are just 3 known mRNA-targets reported in 
humans: TNF-α, GM-CSF and IL-3. (Baou et. al., 2009) 
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TNF-α affects a number of different cell types and it is mainly produced by 
activated macrophages and lymphocytes. TNF-α can act either directly or 
indirectly by inducing other cells to produce cytokines, like hematopoietic growth 
factors. In hematopoiesis TNF-α acts as a positive and as a negative regulator of 
myeloid cell proliferation and differentiation (Rusten and Jacobsen, 1995).  
It has been demonstrated that TNF-α suppresses erythropoiesis by inhibiting the 
generation of Glycophorin-A+ cells derived from CD34+ cells (Xiao et al., 2002). 
TNF-α therefore inhibits the differentation of CD34+ cells into mature eryhthroid 
cells. It has been reported that TNF-α maintains erythropoiesis in vivo and in vitro 
by constraining the proliferative capacity of mature erythroid progenitor cells (Li et 
al., 1989). When CD34+ cells were treated with TNF-α, this resulted in inhibition of 
growth of BFU-E and CFU-E-cultures, which suggests that TNF-α not only inhibits 
the differentiation but also the proliferation of hEPCs (Xiao et al., 2002). 
 
 
As it has been reported that TNF-α is also one of the Tis11d-targets as shown in  
figure 47, and that TTP-knock-down in the mouse system led to an accumulation 
of TNF-α, we also expected that the absence of Tis11d in erythroid cells would 
lead to an accumulation of TNF-α  since the TNF-α-mRNA can’t be degraded 
anymore. TNF-α accumulation would lead to an increased Caspase-8 activation 
and in turn also to an increased Caspase-3 activation, exactly what we found after 
the downregulation of Tis11d by siRNA. 
Unfortunatley we couldn’t detect any significant effects of Tis11d on the TNF-α 
levels, neither on mRNA-level, nor in the supernatant of different appraoches, 
since the TNF-α levels were below the detection limit.  
According the protocols described in Materials and Methods, a partial medium 
change and an adjustment of the cell number to a concentration of 1x106 cells/mL 
was performed daily. Therefore every day part of the supernatant was discarded. 
This could be a possible explanation why the TNF-α content was below the 
detection limit of the ELISA assay and couldn’t be measured. Thus, in further 
experiments the single proliferation-factors should be added in the appropriate 
concentration directly to the cell suspenstion, without performing a partial medium 
change. Thereby a possible TNF- α accumulation in the supernatant could be 
achieved, which would be high enough for measuring by an ELISA assay.  
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On the other side, another possibility could be that in human erythroid cells no 
soluble TNF-α is produced. It could also be that Tis11d is even involved in other 
than the expected signaling pathways and thus Tis11d has no effect on the TNF-α 
levels at all. Figure 48 shows a possible model on how Tis11d could be involved in 
the apoptosis protection in primary human erythroid cells.  
 
 
                              DEGRADATION 
  Tis11d                                 TNF-α mRNA degradation    
            
 
 
   NO Caspase-8 activation 
 
 
   NO Caspase-3 activation 
 
 
                              NO apoptosis 
 
 
 
 
 
 
4.2.3 Tis11d might have anti-apoptotic effects in hEPCs 
 
In summary we could show that the reduction of Tis11d siRNA induces apoptosis 
in human EPCs. As it has been reported that Tis11 proteins are involved in the 
deadenylation and destabilization of a variety of different mRNAs, we suggest that 
the reduction of Tis11d may lead to an abnormal stabilization of one or more 
mRNAs, whose protein products may have a direct or indirect affect on apoptosis 
induction in erythroid cells.  
 
Figure 48: Possible ivolvement of Tis11d in apoptosis-protection 
When Tis11d is present TNF-α is degraded and Caspases are not activated. Without 
activated caspases, apoptosis is not induced.  
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But as we couldn’t demonstrate any effect on the TNF-α levels, maybe Tis11d acts 
on the stability of other ARE-containing mRNAs. A lot of mRNAs encoding 
cytokins, transcription factors, apoptosis regulators contain AU- rich elements 
(ARE) at their 3’ untranslated region. It is estimated that approximatley 8% of 
mRNAs may contain AREs (Bakheet et al., 2003). As the Tis11d knock-down 
induces apoptosis, the unknown mRNA-target is probably directly or indirectly 
involved in the induction of apoptosis. On the other hand, when Tis11d is inducing 
the degradation of this unknown target, it implies that Tis11d might be responsible 
for apoptosis protection in human erythroid progenitor cells.  
 
As already mentioned, studies with Tis11d knockout mice revealed an involvment 
of Tis11d in erythropoiesis and in definitive haematopoiesis (Stumpo et al., 2009).  
During my diploma thesis, I could also show that Tis11d plays an essential role in 
human erythroid progenitor cells. The exact function of Tis11d in humans still 
needs to be further investigated. 
Analysis using microarrays showed that in Tis11d deficient mice, Cxc11-mRNA 
was upregulated (Stumpo et al., 2009). In mice Cxc11 is a homolog of human IL-8, 
which is a chemokine that has been shown to play a critical role in stem cell 
survival, development and homeostasis (Romagnani et al., 2004). Thus, IL-8 could 
be a possible target of Tis11d in human cells, and IL-8 could be also involved in 
the apoptotic process.  
Further studies are required, to find out the mechansism behind the observed 
induction of apoptotis. Microarray analyses of Tis11d deficient cells could reveal 
other upregulated mRNAs, which may be involved in apoptosis or other regulatory 
mechansisms.  
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4.3 FKBP51 
 
In a recent genome-wide profiling of human lung biopsies, FKBP51 has been 
identified as the most highly glucocorticoid-induced gene (Woodruff et al., 
2007). Glucocorticoids bind to the GR, a transcription factor, which is situated in 
the cytoplasm in absence of glucocorticoids. In the cytoplasm the GR is 
associated with the heat shock protein 90 chaperone (HSP90), which keeps the 
receptor in an inactive form (Paakinaho et al., 2010). (Paakinaho et al.).  
FK506-binding protein 51 is a multifunctional co-chaperone protein and a 
component of the GR complex, as it can bind to the HSP90 chaperone protein. 
FKBP51 is also a member of the HSP90 steroid receptor complex, which is a 
cellular chaperone protein that is preventing protein aggregation. The HSP90 
steroid receptor complex maintains the GR in a conformation able to bind to 
steroids (Rees-Unwin et al., 2007). 
As depicted in figure 49, during the formation of the GR complexes, FKBP51 
competes with its homolog FKBP52 for binding to HSP90 (Davies et al., 2002). 
When FKBP51 and FKBP52 are bound to the GR-complex, they differentially 
modulate the interaction of glucocorticoids with the GR. It has been reported that 
FKBP51 decreases the affinity of the glucocorticoids for binding to their receptor 
(Park et al., 2007). 
Davies et al. demonstrated that replacement of FKBP51 by FKBP52 in the GR 
complex induces the translocation of the activated GR complex into the nucleus, 
where it leads to the activation or the inactivation of specific target genes. Thereby 
glucocorticoids can influcence metabolic and developmental processes (Davies et 
al., 2002).  
The FKBP51 expression in response to glucocorticoids has been studied in 
several cell types and tissues in vivo and in vitro. In mononuclear cells isolated 
from peripheral blood it has been demonstrated that dexamethasone-treatment of 
individuals led to a 30-fold increase of FKBP51 mRNA (Vermeer et al., 2004). 
J. Park et al. infected chickens with the Newcastle disease virus (NDV), which is a 
highly immunogenic virus that induces glucocorticoid secretion, to study the 
glucocorticoid-dependent- FKBP51 expression. He observed a 130-fold induction 
of FKBP51-mRNA levels in the liver of NDV-infected chickens. Thereby he 
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demonstrated that glucocorticoids are the main cause of systemic induction of 
FKBP51 (Park et al., 2007). 
It is suggested that FKBP51 is involved in the negative feedback regulation of the 
GR signaling, which means that at high levels of glucocorticoids, the expression of 
FKBP51 is stimulated, whereas high levels of FKBP51 limit the GR activation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 49: FKBP51 is involved in the GR-complex-activation (picture taken 
and modified from: Davies et al., 2002).   
 
 
It has been reported in several publications that the multifunctional FKBP51 might 
be implicated in the control of apoptosis (Bouwmeester et al., 2004; Giraudier et 
al., 2002; Komura et al., 2005). 
Giraudier et al. demonstrated that overexpression of FKBP51 induced a resistance 
to apoptosis with no effect on proliferation. In this study, FKBP51 was 
overexpressed in human megakaryocytes derived from CD34+ cells and after the 
overexpression apoptosis was induced by cytokine deprivation. This resulted in a 
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significant increase in survival of CD34+ cells. Cells remained alive for more than 
five days, whereas 50% of the control cells died after two days of cytokine 
deprivation. Relative to the control cells, the number of Annexin-V-positive cells 
was remarkley increased in cells overexpressing FKBP51. This resistance to 
apoptosis was further confirmed by analysing the Procaspase-3 levels: cells 
overexpressing FKBP51 showed less Caspase-3 activation relative to the control 
cells (Giraudier et al., 2002). 
 
Down-regulation of the FKBP51 levels in malignant melanoma cells by siRNAs led 
to induction of apoptosis. Romano et al. could demonstrate that after irradiation of 
FKBP51-downregulated malignant melanoma cells this resulted in massive 
apoptosis in vivo and in vitro. Cell death was measured by Annexin-V-analysis. 
They could clearly show that irradiation of cells induced a remarkable increase of 
Annexin-V-positive cells compared to the control cells. Typical biochemical 
markers for appoptosis, such as cleaved Caspase-9 and -3 were observed in 
irradiated cells, where FKBP51 has been knocked down. The same results could 
be reported in vivo: When nude mice (tumor-xenograft mice) were treated with a 
single dose of FKBP51- siRNA before the irradiation, this resulted in an extensive 
apoptosis. All those data demonstrated that FKBP51 has a relevant role in 
counteracting apoptotis (Romano et al., 2010).  (Romano et al.). 
 
 
4.3.1 Downregulation of FKBP51 in primary hEPCs induces apoptosis 
 
In accordance with the published data, also in our studies we could show that 
reduction of the FKBP51 levels in primary hEPCs resulted in an apoptotic 
phenotype. In the cytospins of cells with reduced FKBP51 levels a two fold higher 
amount of dead and apoptotic cells was observed. This induction of apoptosis 
could be reproduced in a second independent experiment. Measuring the 
Annexin-V-positive cells, we obtained similar results in even three independent 
experiments using erythroid cultures of three different cord blood samples. The 
reduction of FKBP51 led to a 1,55 fold increase of Annexin-V- positive cells when 
compared to the lowGC- control (lowGC=1).  
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4.3.2 FKBP51 is involved in the NF-kB pathway 
 
Glucocorticoid-mediated FKBP51 expression has been demonstrated to play a 
central role in the activaton of the NF-kB-pathway (Bouwmeester et al., 2004; 
Komura et al., 2005; Romano et al.). 
Park et al. demonstrated that expression of FKBP51 in NDV (Newcastle disease 
virus) infected chickens results in induction of an NF-kB luciferase reporter gene 
even in abscence of glucocorticoids. This supported the existance of an FKBP51-
mediated NF-kB activation pathway (Park et al., 2007). 
As already mentioned in chapter 1.6.3, NF-kB is located in the cytoplasm as an 
inactive form, where it is associated with its inhibitor IkBα. IkBα can be 
phosphorylated by an active IKKα, which leads to the degradation of IkBα by a 
proteasome. Thereby NF-kB is released and translocates into the nucelus, where 
it stimulates the expression of multiple antiapoptotic genes, like Bcl-2, Bcl-XL and 
BFL1.  
Romano et al. reported that FKBP51 knockdown in malignant melanoma cells 
prevented the translocation of NF-kB into the nucleus. In FKBP51-silenced cells 
the lack of NF-kB induction permitted the activation of the apoptotic machinery, 
leading to the cellular suicide. The downregulation of FKBP51 induced by siRNA, 
inhibited the activation of NF-kB by tumor necrosis factor alpha, demonstrating 
that FKBP51 is a key regulator of the NF-kB pathway (Romano et al., 2010). (Romano et al.). 
In 2005 Komura et al. compared the NF-kB activation in the factor dependendent 
UT7/Mpl cell line overexpressing FKBP51 (UT7/FKBP51) with the WT-cell-line 
(UT7/Mpl). They could show that overexpression of FKBP51 led to constitutive NF-
kB activation after cytokine deprivation and a strong reduction of the cytoplasmic 
IKBα in comparison with the wild-type cell line (Komura et al., 2005). 
 
Our analysis on the levels of the components of the NF-kB pathway in hEPCs after 
reduction of FKBP51 showed a decrease of the phosphorylation of NF-kB- and the 
phosphorylation of IKK-α/β.  
Recently it has been reported that FKBP51 is also an essential co-factor for IKKα, 
the inhibitor of IkBα (Bouwmeester et al., 2004). 
Therefore in our case, in absence of FKBP51, IKKα could not any longer be 
phosphorylated, whereas IkBα would not be degraded and thus NF-kB would 
Romano et al., 2010).  
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remain in its inactive form in the cytoplasm and could therefore no longer be 
released into the nucleus to inhibit apoptosis.  
This scheme would fit exactly with our results (reduced pNF-kB and pIKK α/β- 
levels). The data of our study demonstrate that also in erythroid cells FKBP51 is 
involved in the NF-kB activation and that it might act as well as a cofactor of IKKαβ, 
since also these levels were down-regulated in the abscence of FKBP51.  
 
 
4.3.3 FKBPP51 might be involved in the JAK/STAT pathway 
 
FKBP51 can not only phosphorylate IKKαβ and thereby induce the activation of 
NF-kB, it has also been shown to be able to inhibit Calcineurin (CaN) (Baughman 
et al., 1995; Nair et al., 1997). 
Calcineurin is a calcium-calmodulin-regulated serine/threonine phosphatase, 
which has been reported to dephosphorylate IkBs (Frantz et al., 1994). Thus, 
Calcineurin regulates the NF-kB pathway by dephosphorylating IkB and preventing 
its degradation by the proteasome and thereby promoting apoptosis. It has been 
shown that overexpression of FKBP51 in a UT-7/Mpl cell line induced the 
resistance to apoptosis through inhibition of the calcineurin signal transduction 
pathway (Giraudier et al., 2002). FKBP51 regulates Calcineruin activity either 
alone or by binding to an unknown cellular protein. 
 
On the other side Calcineurin is also involved in the control of the JAK/STAT 
pathway, as it has been shown to dephosphorylate STAT3 (Liang et al., 1999). 
It has been demonstrated that overexpression of FKBP51 in pathologic 
megacaryoctes from IMF patients (idiopathic myelofibrosis) induced a sustained 
activation of the JAK2/STAT5 pathway and a sustained activation of STAT5 
(Komura et al., 2003). This STAT5 activation was associated with a persistent Bcl-
XL expression and an absence of Caspase-3 cleavage after cytokine deprivation. 
It was also reported that in this FKBP51-overexpressing cell-line, STAT5 was 
dephosphorylated much slower, which was related to a persistent JAK2 
phosphorylation. Calcineurin may act directly or indirectly on JAK2 
phosphorylation to modify the STAT5 phosphorylation state. 
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Figure 50 shows a possible model for downstream signaling of FKBP51, it 
hypothesizes how FKBP51 might inhibit apoptosis: either through inhibition of 
Calcineurin or through IKK-αβ activation. 
 
When FKBP51 is present: 
In presence of FKBP51 Calcineurin is inhibited and can’t lead to 
dephosphorylation of JAK2. Active JAK2 in turn phosphorylates STAT5 or STAT3, 
which act as transcription factors and induce the expression of antiapoptotic genes 
like Bcl-2, which protect cells from apoptosis.  
 
When FKBP51 is absent: 
On the other hand, in the absence of FKBP51, Calcineurin is no longer inhibited 
and leads to dephosphorylation of JAK2 and IkB, which blocks NF-kB. Inactive 
JAK2 in turn can’t phosphorylate STAT5/STAT3, which thus can no longer 
stimulate the expression of antiapoptotic genes, whereby cells undergo apoptosis.  
 
The role of the Calcineurin pathway in the myeloid lineages is poorly understood. 
In our studies in primary human erythroid progenitor cells we didn’t yet analyse the 
relation of FKBP51 to Calcineurin and the JAK/STAT pathway. We would expect 
that the absence of FKBP51 would lead to an increase of Calcineurin, -if it is even 
expressed in hEPCs-, and therefore decreased levels of phosphorylated STAT3, 
JAK2 and STAT5 and as well as decreased expression of the antiapoptotic genes 
Bcl-2, Bcl-XL and BFL1 are expected. The decrease of the NF-kB-levels could 
already be demonstrated, but in further studies the expression of Bcl-2, Bcl-XL and 
BFL1 should be analysed. 
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Figure 50: Possible model for downstream signaling of FKBP51 
FKBP51 might inhibit apoptosis either through Calcineurin inhibition or IKK-αβ activation. 
P 
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Another issue in our experiments was that the seen apoptotic phenotype (1,5- fold 
increase of apoptotic cells relative to the control) was not as prominent as in other 
reported FKBP51-silenced cells (Romano et al., 2010). In further experiments 
apoptosis could therefore be induced by factor deprivation -as reported in 
experiments with other factor dependent cell lines (Giraudier et al., 2002) - to 
further excite the effects of the FKBP51 knock-down in erythroid cells.  
 
Taken together, we could show that the reduction of FKBP51 in primary human 
erythroid progenitor cells leads to an increase of apoptosis. FKBP51 seems to be 
involved in apoptosis protection, which might be mediated through IKKαβ-
interaction and subsequent NF-kB activation. Whether FKBP51 in hEPCs is also 
involved in the JAK/STAT-pathway and is interacting with Calcineurin remains still 
unclear. Further studies will be required in which also the expression of the 
antiapoptotic genes (Bcl-2, Bcl-XL and BFL1) are analysed. 
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4.4 Glucocorticoids prevent apoptosis in hEPCs 
 
Glucocorticoids are steroid hormones involved in several developmental and 
biological processes. Binding of glucocorticoids to their Receptor leads to 
activation and translocation of the GR into the nucleus, where it regulates different 
target genes.  
Nuclear steroid receptors, such as the GR, were reported to modulate apoptosis in 
different cell types (Amaral et al., 2009). It has been demonstrated that GR 
supress spontaneous apoptosis of neutrophils and TNF-α mediated apoptosis of 
mouse fibroblasts (Pagliacci et al., 1993). Also in fibrosarcoma development the 
GR has been shown to inhibit apoptosis by transcriptionally activating the 
antiapoptotic gene Bcl-XL (Gascoyne et al., 2003). Even in human mammary 
epithelial cell lines, GR can activate several survival pathways (Moran et al., 2000). 
Furthermore, GR are involved in both, the induction and prevention of apoptosis 
depending on the cell type. Several studies were performed to identify GC-induced 
genes by microarray analyses, but the menchanism how exactly many of the 
target genes modulate apoptosis remains still unclear. 
 
In my diploma thesis I analysed the function of three different GR-targets genes: 
Raf-1, Tis11d and FKBP51 by siRNA mediated knock-down (downregulation). 
While there were no remarkable effects after the Raf-1 downregulation, the 
reduction of Tis11d and FKBP51 led to an increase of apoptotis. Thus, the latter 
GR-targets seem to be involved in anti-apoptotic mechanisms of erythroid 
progenitor cells.  
How both regulate the survival pathway reamains still unclear. We propose that 
Tis11d leads to the destabilisation of one or more mRNAs, whose protein products 
may have a direct or indirect affect on apoptosis induction in erythroid cells. 
Whether the mRNA target involved in the apoptotic process, is TNF-alpha, as we 
first assumed, needs further investigation. There is strong evidence that the 
antiapoptotic effect of FKBP51 is mediated either through inhibition of the 
calcineurin activity, or over a glucocorticoid-dependent-FKBP51-induced-NF-kB 
signaling pathway.  
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As we could show that Tis11d knock-down at the same time led also to a 
dramatically decrease of FKBP51 on mRNA level, a possible interaction of those 
two GR target genes, both involved in antiapoptotic mechanisms, could be feasible. 
We found out that the 3’-untranslated region of the FKBP51 mRNA contains four 
adenine-uridine (AU) rich elements (ARE), which have been reported to be the 
binding side of Tis11d. But if Tis11d is capable to bind to FBKP51 and thereby to 
induce its degradation needs to be analysed. Thus, the absence of Tis11d should 
lead to an accumulation and not to a down-regulation of FKBP51. This possible 
interaction is still entirely speculative and requires further experiments and 
analysis.  
In summary we could show that in human erythroid progenitor cells glucocorticoids 
are involved in the antiapoptotic mechanism. 
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